cellbank产品目录 | Amresco官网

RIKEN是日本大的综合性研究机构，以各种科学学科的高质量研究而闻名。RIKEN成立于1917年，是东京的私人研究基金会，其规模和范围迅速发展，如今已遍布日本各地的研究中心和研究机构网络。

cellbank产品目录如下：

货号	品名	特征
RCB0002	ARM193	Anti-recA protein mAb (IgG2b)
RCB0005	BALB/3T3 clone A31	Contact-inhibited semi-normal cell line
RCB0007	HeLa	Just like ATCC CCL 2, HeLa
RCB0008	V79	Chinese hamster lung fibroblast
RCB0009	PC-12	Pheochromocytoma, differentiate by NGF stimulation
RCB0012	M227	Infected with ts mutant of Kirsten sarcoma virus
RCB0016	CCRF-HSB-2	T cell leukemia
RCB0026	PAb1400	Anti-SV40 large T antigen mAb (IgG)
RCB0027	K562	Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .
RCB0032	FM3A FT-101	Temperature-sensitive, forms multiple nuclei
RCB0033	FM3A tscl.T85 Tsai	Temperature-sensitive at chromosome condensation
RCB0034	FM3A ts T244	Temperature-sensitive at DNA polymerase
RCB0035	WEHI-3	Secrete growth factors for hematpoietic stem cells
RCB0036	C127	Host for bovine papiloma virus
RCB0041	HL60	Differentiate to granulocytes and monocytes
RCB0043	NRK	Contact-inhibited semi-normal, original of NRK49F
RCB0056	NIH3T3/14-1	Spontaneous transformant of NIH3T3
RCB0057	NIH3T3/13C7	SV40 large T (tsA58)-pBR322 transformed NIH3T3.
RCB0063	JTC-15	Subclone of AH-66, lost transplantability in rats.
RCB0065	JTC-27	Ascites hepatoma.
RCB0067	M	Capable to form collagen network
RCB0069	RLC-16	Epithelial cell from rat liver
RCB0070	RLC-18	Non tumorigenic in nude mice
RCB0072	RLC-27	Liver-derived cell, tumorigenic in nude mice
RCB0074	JTC-19	Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.
RCB0075	RCR-1	Astroglia cell line
RCB0076	LYM-1	Sticky cell from lymph node.
RCB0083	HLC-1	Lung adenocarcinoma
RCB0086	FM3A	Mammary carcinoma, grow in vitro and in vivo
RCB0095	P3·NS-1/1·Ag4.1	Myeloma
RCB0096	Don(D-6)	Pseudodiploid, two marker chromosomes
RCB0097	CHL	Widely used in chromosome aberration test
RCB0098	A549	Lung carcinoma, refer to ATCC CCL185
RCB0101	L·P3	Protein- & lipid-free medium growing
RCB0102	IC-2	Mast cell precursor, respond to IL-3. Conditioned medium.
RCB0112	NRK49F	Contact-inhibited semi-normal cell line
RCB0115	ARM321	Anti-recA protein mAb (IgG1)
RCB0116	7501	S. cerevisiae Endo.Sce I large subunit mAb (IgG2b)
RCB0120	LT4Tr	Spontaneous transformant of LT4
RCB0135	L5178Y	Rapidly growing lymphoma
RCB0136	M10	Highly sensitive to X-ray irradiation
RCB0137	M10^(-)	Resistant to 6TG, isolated from M10
RCB0138	LX830	Highly sensitive to X-ray irradiation
RCB0142	Ehrlich	Ehrlich's ascite tumor
RCB0146	P3-X63-Ag8.653	Myeloma
RCB0153	HUC-F	Normal umbilical cord fibroblast, female
RCB0156	305M	Normal human skin fibroblast
RCB0159	HS-K	Normal diploid fibroblast from Japanese
RCB0162	NHSF46	Diploid fibroblast from normal Japanese skin.
RCB0163	RGB3T3-1	Original cloned line from RCB, just like BALB/3T3
RCB0164	RGB3T3-5	Siblings of RGB3T3-1, contact-inhibited
RCB0165	REF-RGB	Suitable as feeders for hybridoma cloning
RCB0169	M1	Differentiate to macrophage and granulocyte
RCB0171	7T1	Contact inhibited, may transform spontaneously
RCB0174	SUSM-1	Transformed in vitro with carcinogen
RCB0180	MDBK	Kidney epithelial cell, equiv. to ATCC CRL6071
RCB0183	RK13	Susceptible to rubella virus, equiv. to ATCC CCL37
RCB0184	OLF-136	Fish (medaka) fin fibroblast. Application consideration
RCB0185	CAEP	Gold fish erythrophoroma with 4n chromosomal mode
RCB0186	CAF	Pinna fibroblast
RCB0187	OLHE-131	H04C medaka hepatoma pretreated with MAM-acetate. Application consideration
RCB0188	OLME-104	HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Cell growth is slow. Application consideration
RCB0191	HeLa.S3	Most famous cultured human cell line
RCB0193	KMM-1	Human myeloma. Lambda- chain producing.
RCB0195	PAb419	Anti-SV40 large T antigen mAb (IgG)
RCB0197	HUC-Fm	Normal umbilical cord fibroblast, male
RCB0202	A431	High level of EGF receptor
RCB0205	BU25 TK-	Thymidine kinase defective HeLa
RCB0206	MOLT-4	T cell leukemia, the same patient as RCB1164 MOLT-3.
RCB0207	MRC-5 SV1 TG1	SV40-transformed, 6TG-resistant and HAT-sensitive.
RCB0208	LTK-	Thymidine kinase defective L cell
RCB0209	SP2/0-Ag14	Myeloma
RCB0210	HF19	Normal human lung fibroblast.
RCB0211	MRC-5	Normal embryonic lung fibroblast.
RCB0212	CT14-G4	Anti human c-myc p62 mAb (IgG1.kappa)
RCB0213	NS0	Myeloma. Application consideration
RCB0218	MRC-5, known PDL	Normal embryonic lung fibroblast with accurate PDL
RCB0222	NB1RGB	Normal human skin fibroblast, RCB original
RCB0224	ST2	Bone marrow stroma cell-derived
RCB0243	Nil2C2	Highly metastatic sarcoma
RCB0244	Nil2C1	Highly metastatic sarcoma
RCB0245	Nil1C1	Highly metastatic sarcoma, synthesize hematoside
RCB0247	10T1/2	Clone 8, Contact-inhibited semi-normal
RCB0248	3T6	Non-contact inhibited
RCB0249	CKT-1	Very flat and thin kidney epithelial cell
RCB0251	VA-13	SV40-transformed WI-38.
RCB0252	W-V	SV40-transformed Werner's syndrome fibroblast
RCB0256	BALL-1	Typical human B cell leukemia.
RCB0266	CLA1RGB	Pseudo congenital lactic acidosis.
RCB0270	KG-1-C	Glioma, S-100 Protein producing. Cell growth is slow.
RCB0271	HeLa S3 (SC)	Suspension culturable. Useful for JIS medium inspection
RCB0273	BRL	ES cell differentiation inhibitory activity (DIA)
RCB0275	SES-MaBr-1	Cabbage armyworm cell line applicable to large scale insect virus production.
RCB0276	SES-MaBr-3	Cabbage armyworm cell line applicable to large scale production of insect virus.
RCB0278	NIAS-MB-25	Show finely branched cytoplasmic processes
RCB0279	NIAS-MaBr-92	Susceptible to nuclear polyhedrosis virus
RCB0282	NFSa Y83	In vivo transplantable highly metastatic sarcoma
RCB0283	C-1300	Highly metastatic neuroblastoma
RCB0284	Sq-1979	Metastatic epithelial cell
RCB0285	CHO-K1	Widely used cell line, especially for biotechnol
RCB0286	tk^(-)ts13	Thymidine kinase-defective mutant of ts13
RCB0288	3Y1-B clone 1-6-2	Subclone of 3Y1-B clone 1.
RCB0289	3Y1-B cl 1-6-K5-4-2	Subclone of 3Y1-B clone 1-6.
RCB0290	3Y1-B clone 1	Mother clone of 3Y1 series
RCB0291	3Y1ts-101	Temperature-sensitive mutant of 3Y1 (see library).
RCB0292	3Y1tsC102	Temperature-sensitive mutant of 3Y1, group C
RCB0293	3Y1ts-103	Temperature-sensitive mutant of 3Y1 (see library).
RCB0294	3Y1ts-104	Temperature-sensitive mutant of 3Y1 (see library).
RCB0295	3Y1ts-105	Temperature-sensitive mutant of 3Y1 (see library).
RCB0296	3Y1tsA106	Temperature-sensitive mutant of 3Y1, group A
RCB0297	3Y1tsB107	Temperature-sensitive mutant of 3Y1, group B
RCB0298	3Y1ts-108	Temperature-sensitive mutant of 3Y1 (see library).
RCB0299	3Y1ts-109	Temperature-sensitive mutant of 3Y1 (see library).
RCB0301	3Y1ts-111	Temperature-sensitive mutant of 3Y1 (see library).
RCB0302	3Y1tsC112	Temperature-sensitive mutant of 3Y1, group C
RCB0303	3Y1tsC113	Temperature-sensitive mutant of 3Y1, group C
RCB0304	3Y1ts-114	Temperature-sensitive mutant of 3Y1 (see library).
RCB0305	3Y1ts-115	Temperature-sensitive mutant of 3Y1 (see library).
RCB0306	3Y1tsC116	Temperature-sensitive mutant of 3Y1, group C
RCB0307	3Y1ts-117	Temperature-sensitive mutant of 3Y1 (see library).
RCB0308	3Y1ts-118	Temperature-sensitive mutant of 3Y1 (see library).
RCB0309	3Y1tsC119	Temperature-sensitive mutant of 3Y1, group C
RCB0310	3Y1ts-120	Temearature-sensitive mutant of 3Y1 (see library).
RCB0311	3Y1tsF121	Temperature-sensitive mutant of 3Y1, group F
RCB0312	3Y1ts-122	Temperature-sensitive mutant of 3Y1 (see library).
RCB0313	3Y1tsD123	Temperature-sensitive mutant of 3Y1, group D
RCB0314	3Y1tsD124	Temperature-sensitive mutant of 3Y1, group D
RCB0315	3Y1tsG125	Temperature-sensitive mutant of 3Y1, group G
RCB0316	3Y1tsF126	Temperature-sensitive mutant of 3Y1, group F
RCB0317	3Y1ts-201	Temperature-sensitive mutant of 3Y1 (see library).
RCB0318	3Y1ts-202	Temperature-sensitive mutant of 3Y1 (see library).
RCB0319	3Y1tsH203	Temperature-sensitive mutant of 3Y1, group H
RCB0320	3Y1tsE204	Temperature-sensitive mutant of 3Y1, group E
RCB0321	3Y1tsC205	Temperature-sensitive mutant of 3Y1, group C.
RCB0322	3Y1tsD206	Temperature-sensitive mutant of 3Y1, group D
RCB0323	3Y1-SB-15	Tetraploid clone of 3Y1
RCB0324	3Y1-SB-16	Tetraploid clone of 3Y1
RCB0325	3Y1BU^(r-1)	Thymidine kinase-defective mutant of 3Y1
RCB0326	3Y1BU^(r-2)	Thymidine kinase-defective mutant of 3Y1
RCB0327	3Y1BU^(r-3)	Thymidine kinase-defective mutant of 3Y1
RCB0328	Ad12-3Y1-Z11	3Y1 transformed with adenovirus type 12
RCB0329	Ad12-3Y1-Z13	3Y1 transformed with adenovirus type 12
RCB0330	Ad12-3Y1-Z19	3Y1 transformed with adenovirus type 12
RCB0331	Ad12-3Y1-W5	3Y1 transformed with adenovirus type 12
RCB0332	E1A-3Y1-1	3Y1 transformed with adenovirus type 12 E1A gene
RCB0333	E1A-3Y1-2	3Y1 transformed with adenovirus type 12 E1A gene.
RCB0334	E1A-3Y1-3	3Y1 transformed with adenovirus type 12 E1A gene.
RCB0335	in203-3Y1-7	3Y1 transformed with adenovirus in203.
RCB0336	in203-3Y1-19	3Y1 transformed with adenovirus in203.
RCB0337	in203-3Y1-23	3Y1 transformed with adenovirus in203.
RCB0338	Ad2-3Y1-1	3Y1 transformed with adenovirus type 2
RCB0339	Ad2-3Y1-2	3Y1 transformed with adenovirus type 2.
RCB0340	Ad2-3Y1-3	3Y1 transformed with adenovirus type 2.
RCB0343	SV-3Y1-C66	3Y1 transformed with SV40 virion.
RCB0344	A640-3Y1-1	3Y1 transformed with SV40 tsA640
RCB0347	dl-884-3Y1-KO1	3Y1 transformed with SV40 dl-884
RCB0350	Py-3Y1-S2	3Y1 transformed with mouse polyoma virus
RCB0353	SR-3Y1-1	3Y1 transformed with Rous sarcoma virus
RCB0354	SR-3Y1-2	3Y1 transformed with Rous sarcoma virus
RCB0356	HR-3Y1-1	3Y1 transformed with v-Ha-ras oncogene
RCB0357	HR-3Y1-2	3Y1 transformed with v-Ha-ras oncogene
RCB0359	NG-3Y1-D303	3Y1 transformed with nitrosoguanidine
RCB0371	NG-3Y1-T18D	3Y1 transformed with nitrosoguanidine
RCB0379	mos-3Y1-10	3Y1 transformed with v-mos oncogene
RCB0380	mos-3Y1-16	3Y1 transformed with v-mos oncogene
RCB0381	V12S-3Y1-2	3Y1 transformed with adenovirus type 12 12S-E1A
RCB0384	V13S-3Y1-4	3Y1 transformed with adenovirus type 12 13S-E1A
RCB0388	NCU-F1	Ehlers-Danlos syndrome
RCB0389	NCU-F2	Morquio syndrome
RCB0390	NCU-F3	Wilson's disease
RCB0391	NCU-F4	Wilson's disease
RCB0393	NCU-F6	Citrullinemia
RCB0394	NCU-F7	Citrullinemia
RCB0395	NCU-F8	Wilson's disease
RCB0397	NCU-F10	Cockayne's syndrome
RCB0402	HeLa·P3	Protein- & lipid-free medium growing
RCB0403	CHO-K1 (SC)	CHO-K1 maintained in suspension culture.
RCB0404	SES-MaBr-4	Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.
RCB0405	NIAS-LeSe-11	Susceptible to insect viruses.
RCB0407	WS2TKB	Werner's syndrome
RCB0409	WS1TKB	Werner's syndrome, the same patient as RCB0433 WS1TKB2.
RCB0410	MEN1RGB	Fibroblasts from multiple endocrine neoplasia
RCB0411	HaP-T1	Mucin producing, BHP-induced pancreatic tumor
RCB0412	NIAS-PX-64	Pupal ovary hemocyte.
RCB0413	NIAS-MB-32	Show finely branched cytoplasmic processes. Application consideration
RCB0414	NIAS-MaBr-93	larval hemocyte
RCB0417	KU-1	Bovine B cell leukemia without virus production
RCB0418	KU-17	Bovine leukemia virus producing. Surface Ig (+). Application consideration
RCB0420	BHK-21C13-2P	Culturable in suspension, cf. ECACC ( BHK-21C13-3P).
RCB0421	MEN2RGB	Fibroblasts from multiple endocrine neoplasia
RCB0423	BL312	Bovine derived lymphocyte.
RCB0426	SK-N-SH	Neuroblastoma, a target in CTL assay
RCB0428	Saos-2	Osteogenic sarcoma
RCB0429	SES-MaBr-5	Larval fat body hemocyte.
RCB0431	T24	Bladder transitional-cell carcinoma
RCB0432	MT-5	MNNG-initiated clone of BALB/3T3 clone A31
RCB0433	WS1TKB2	Werner's syndrome, the same patient as RCB0409 WS1TKB.
RCB0434	J774.1	Macrophage-like cell
RCB0435	U-937 DE-4	Cloned U-937, differentiate with TNF
RCB0436	HUC-F2	Normal umbilical card fibroblast, female
RCB0437	HUC-Fm2	Normal umbilical cord fibroblast, male
RCB0438	LC-1/sq-SF	Lung Cancer-1/squamous (RCB0455 LC-1/sq), serum-free cultured. Application consideration
RCB0439	LC-1F	Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.
RCB0440	LC-2/ad	Adenocarcinoma, moderately differentiated. Cell growth is slow. Application consideration
RCB0441	SCCKN	Highly sensitive to bleomycin
RCB0443	TC-YIK	Integrating HPV16, neurosecretory granules(+)
RCB0444	RERF-LC-AI	Japanese lung squamous carcinoma.
RCB0447	ARLJ301-3	Diploid rat liver epithelial cell line
RCB0448	ARLJ301-3TR1	Spontaneous transformant of ARLJ301-3
RCB0449	Anr4	EJ-ras oncogene transformed ARLJ301-3
RCB0450	Anr9-1	EJ-ras oncogene transformed ARLJ301-3
RCB0451	Anr13-1	EJ-ras oncogene transformed ARLJ301-3
RCB0452	HTC/C3	Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin
RCB0453	SHOK	Contact-inhibited hamster embryonal cell line
RCB0455	LC-1/sq	Lung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F. Cell growth is slow.
RCB0457	BM-N	Useful for recombinant BmNPV expression. Application consideration
RCB0466	Lu-134-A	Small cell carcinoma, classic type. See Lu-134-B. Application consideration
RCB0467	Lu-134-B	Small cell carcinoma, classic type. See Lu-134-A. Application consideration
RCB0468	Lu-135	Small cell carcinoma, variant type. Application consideration
RCB0469	Lu-139	Small cell carcinoma, classic type. Application consideration
RCB0470	Lu-140	Small cell carcimoma, classic type. Application consideration
RCB0471	CYNOM-K1	Cynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB0473	DD762	Mammary tumor cell line without C-type virus
RCB0474	K562/MTX-2	Methotrexate(MTX)-resistant K562 cell line
RCB0475	ILT-Mat	IL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).
RCB0476	Had-1	Newcastle disease virus resistant
RCB0477	NB9	Neuroblastoma ( Another name : CHP-212, PMID: 6871857 ) . N-myc gene amplification. Application consideration
RCB0478	NB16	Neuroblastoma. N-myc gene amplification.
RCB0480	NB69	Neuroblastoma. N-myc gene unamplified tumor. Cell growth is slow. Application consideration
RCB0481	TNB1	Neuroblastoma ( Another name : TGW, PMID: 2335222 ). N-myc gene amplification. Application consideration
RCB0482	MC-NB-1	Neuroblastoma. N-myc gene amplicon analysis. Application consideration
RCB0483	LA-N-1	Neuroblastoma. N-myc gene amplification.
RCB0484	LA-N-2	Neuroblastoma. N-myc gene amplification.
RCB0485	LA-N-5	Neuroblastoma. N-myc gene amplification.
RCB0486	CHP-126	Neuroblastoma. N-myc gene amplification. Cell growth is slow. Application consideration
RCB0487	CHP-134	Neuroblastoma. N-myc gene amplification. Application consideration
RCB0488	3Y1-B clone 1-6	Standard clone of 3Y1 series. So called 3Y1
RCB0489	NEC8	Embryonal carcinoma, testis.
RCB0490	NEC14	Embryonal carcinoma, testis. Application consideration
RCB0492	OTCD1TKB	OTC(-), X-linked, dominant (XD)
RCB0494	NEC15	Embryonal carcinoma, testis. Application consideration
RCB0495	KU812	Chronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.
RCB0496	KU812E	Chronic myelogenous leukemia , subclone of RCB0495 KU812.
RCB0497	KU812F	Chronic myelogeneous leukemia, subclone of RCB0495 KU812.
RCB0500	HGC-27	Gastric cancer undifferentiated, mucin producing
RCB0503	HeLa.S3(Mer^(-))	Repair deficient (mer~)
RCB0504	MR1-3	MNNG-reistant HeLa.S3(Mer~) cells
RCB0505	MR6	MNNG-resistant HeLa.S3(Mer~) cells
RCB0507	MR10-1	MNNG-resistant HeLa.S3(Mer~) cells
RCB0508	H-EMC-SS	Extraskeletal myxoid chondrosarcoma
RCB0510	ACL-15	Metastasis to liver, lung
RCB0511	RCN-9	Metastasis to liver, lung
RCB0512	RCN-H-4	Metastasis to liver
RCB0513	SKN	Estradiol-17 beta responsive leiomyosarcoma
RCB0515	HSKTC	Krukenberg tumor cell line
RCB0520	WR216	APRT(-) EB transformed B cell line
RCB0521	HFL-I	Normal embryonic lung fibroblast
RCB0522	HFL-II	Normal embryonic lung fibroblast
RCB0523	HFL-III	Normal embryonic lung fibroblast
RCB0524	HFL-AE-I	Human lung fibroblasts derived from anencephalous embryo.
RCB0525	HFL-AE-II	Human lung fibroblasts derived from anencephalous embryo.
RCB0526	Jyg-MC(A)	murine mammary tumor cell lines. High level MMTV producer line.
RCB0527	Jyg-MC(B)	Murine mammary tumor cell lines. .Higher incidence in lung metastasis.
RCB0528	MtT/S	Estrogen-induced tumor. Growth hormone producing. Application consideration.
RCB0529	MtT/Se	Estradiol-dependent pituitary tumor. Application consideration.
RCB0530	MtT/SM	Growth hormone, prolactin producing. Application consideration.
RCB0531	TtT/M-87	Macrophage-like tumor dependent on L929 conditioned medium. Conditioned medium.
RCB0533	Y1	Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.
RCB0534	PK15	Buck-up culture of ECA86103005. Foot & mouth disease.
RCB0535	RAW 264	Buck-up culture of ECA8510291 . Mouse leukemic monocyte. Abelson leukemia virus induced. Application consideration
RCB0536	STO	Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.
RCB0537	JM	Buck-up culture of ECA86010201. . Human T cell line with the ability to grow HIV, the same patient as Jurkat.
RCB0538	PU5-18	Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501 .
RCB0540	HAL-01	Acute lymphatic leukemia
RCB0544	MBT-2	Murine transitional cell carcinoma induced by FANFT
RCB0545	OHTA	Mouse embryonic carcinoma
RCB0546	AT-PDH1TKB	Pyruvate dehydrogenase deficiency fibroblasts.
RCB0548	IA-5	Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic assay.
RCB0549	Cle-H3	NIH3T3 transformant expressing human activated k-ras-2.
RCB0550	Cle-H3^(neo+)	pSV2neo-introduced G418-resistant Cle-H3 mutant.
RCB0554	IA-LM	Japanese lung large cell carcinoma
RCB0555	GCIY	Stomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.
RCB0556	NIAS-PX-58	Pupal ovary hemocyte.
RCB0557	B16 melanoma 4A5	Melanin pigment producing mouse melanoma. Application consideration
RCB0558	LLC	Highly metastatic and drug-resistant mouse tumor. Application consideration
RCB0559	K-1.fl	SFFV producing Friend leukemia cell line. Non-differentiating.
RCB0560	F5-5.fl	Friend leukemia. Differentiate to erythroblastoid cells with benzidine etc.
RCB0561	T-3-Cl-2-0.fl	Friend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl
RCB0562	TSFAT-3.fl	Friend leukemia. Differentiate to erythroblastoid cells.
RCB0565	ATDC5	Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.
RCB0566	CGM1	EB transformed B cell line
RCB0568	ULF-23	Cold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).
RCB0569	707.fl	Friend leukemia cell line. High ability to differentiate to erythroblastoid cells.
RCB0570	GM86.fl	Friend leukemia cell line from DBA/2 mouse.
RCB0571	FVTCT.fl	Friend leukemia cell line from BALB/c mouse. Virusnon-producing.
RCB0580	SF8402	Control from a nonexposed individual with breast cancer, different specimen from RCB0635
RCB0582	SF8404	Control from a nonexposed individual without cancer
RCB0583	SF8405	Control from a nonexposed individual without cancer.
RCB0584	SF8406	Control from a nonexposed individual without cancer.
RCB0585	SF8657	Control from a nonexposed individual with stomach cancer
RCB0587	SF8759	Atomic bomb survivor with breast cancer
RCB0588	SF8760	Atomic bomb survivor with breast cancer.
RCB0589	SF8761	Control from a nonexposed individual without cancer.
RCB0590	SF8762	Atomic bomb survivor with breast cancer.
RCB0591	HNS1A	Salamander cell line with large chromosomes. Cell growth is slow.
RCB0592	HNS2	Larger epithelial cells than HNS1A.
RCB0593	HNS3	Salamander cell line. Fibroblast-like cells.
RCB0594	HNS4	Salamander cell line. Epithelial-like cells.
RCB0595	HNS5	Salamander cell line. Fibroblast-like cells. Cell growth is slow.
RCB0596	SF8758	Atomic bomb survivor with breast cancer
RCB0597	SF8656	Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.
RCB0598	SF8655	Atomic bomb survivor without cancer.
RCB0600	SF8653	Atomic bomb survivor without breast cancer but with thyroid cancer.
RCB0602	SF8650	Atomic bomb survivor with breast cancer
RCB0603	SF8649	Atomic bomb survivor with breast cancer
RCB0604	SF8647	Atomic bomb survivor with breast cancer.
RCB0605	SF8546	Control from a nonexposed individual without cancer.
RCB0608	SF8543	Control from a nonexposed individual with breast cancer
RCB0610	SF8541	Control from a nonexposed individual with uterus cancer
RCB0614	SF8536	Atomic bomb survivor without cancer
RCB0617	SF8433	Atomic bomb survivor with breast cancer
RCB0620	SF8429	Atomic bomb survivor with breast cancer
RCB0621	SF8428	Atomic bomb survivor with breast cancer, different specimen from RCB0624
RCB0624	SF8425	Atomic bomb survivor with breast cancer, different specimen from RCB0621.
RCB0631	SF8416	Atomic bomb survivor with breast cancer
RCB0633	SF8414	Control from a nonexposed individual with breast cancer
RCB0634	SF8413	Control from a nonexposed individual with chest cancer
RCB0635	SF8410	Control from a nonexposed individual with breast cancer, different specimen from RCB0580.
RCB0637	CTLL-2	Cytotoxic T-cell line. IL-2 dependent.
RCB0638	TCS	Keratinizing cervix squamous carcinoma, CEA(+)
RCB0641	EoL-1 cell	Eosinophilic leukemia. Differenciate by n-butylate treatment.
RCB0644	D134	MoAb IgM to sea urchin sperm dynein alpha-heavy chain.
RCB0646	D264	MoAb IgM to sea urchin sperm dynein beta-heavy chain.
RCB0648	D308	MoAb IgM to sea urchin sperm dynein beta-heavy chain.
RCB0649	D52	MoAb IgM to sea urchin sperm dynein IC1.
RCB0650	D9	MoAb IgM to sea urchin sperm dynein IC2.
RCB0651	D58	MoAb IgG1 to sea urchin sperm dynein IC2.
RCB0654	D16	MoAb IgG1 to sea urchin sperm dynein IC3.
RCB0657	HOKUG	Glassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.
RCB0658	HHUA	Expressing receptor to estrogen and progesterone. Cell growth is slow.
RCB0659	HOUA-I	Poorly differentiated adenocarcinoma. Cell growth is slow.
RCB0660	HTMMT	Mixed Mullerian tumor.
RCB0662	HOTHC	Thyroid tumor. TAF, G-CSF, colloid producing.
RCB0665	HFWT	Wilms' tumor. CA125 and TPA producing.
RCB0666	HSNB	N-myc propagated. Neuron specific enolase producing.Application consideration
RCB0669	PCH42-63	Hybridoma against differentiated PC-12 cell surface
RCB0673	PCH41-43	Hybridoma against differentiated PC-12 cell surface
RCB0674	PCH41-44	Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
RCB0676	PCH42-58	Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
RCB0678	PCH54-37	Hybridoma against differentiated PC-12 cell surface
RCB0679	HDC	Mother of a Down's syndrome child. 46XX,t(2/q2/q)
RCB0680	HKBMM	Human malignant meningioma.
RCB0684	HFL-AE-III	Human lung fibroblasts derived from anencephalous embryo.
RCB0685	SKG-II-SF	Large cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.
RCB0687	KP-N-NS	Adrenal neuroblastoma derived from brain metastasis
RCB0688	QG-U	Japanese cervix carcinoma.
RCB0689	TCO-2	Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).
RCB0690	HOTHC-SF	Serum-free, protein-free cultured HOTHC cells
RCB0697	GM2-1TKB	Tay-Sachs' disease
RCB0698	HFSKF-II	Normal human fetal skin fibroblast.
RCB0700	HTMM	Malignant melanoma from lympho node.
RCB0701	143B/TK^(-)neo^(R)	v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.
RCB0702	WI-38	The most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.
RCB0704	WI-38	The most famous normal human fibroblast. Obtained directly from L. Hayflick.
RCB0705	10H	Anti poly(ADP-ribose) IgG3 kappa producing.
RCB0708	HF10B4	Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.
RCB0709	HyLDH·YK-1	Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.
RCB0710	HyLDH·YK-2	Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium
RCB0711	HyGPD·YK-1-1	Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.
RCB0713	HTUD1	Large cells with large chromosomes.
RCB0715	CHAUT-G	Smooth muscle cell sarcoma from Chinese hamster.
RCB0721	GOTO·P3	Subline of GOTO. Protein-free medium adapted. Cell growth is slow.
RCB0725	MS-1	Small lung carcinoma. PTHrP producing.
RCB0733	NLS-6-5	Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.
RCB0735	OS-RC-2	Renal tumor cell from a Japanese. Transplantable to nude mice.
RCB0736	DJM-1	Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
RCB0738	MTHC-1	Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.
RCB0739	MTHC-2	Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.
RCB0740	MTHC-3	Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.
RCB0748	Mm1	Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.
RCB0749	MFH-ino	Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
RCB0750	TLR2	Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.
RCB0752	TKD2	Kidney epithelial cells containing temperature sensitive SV40 large T antigen. Compared to TKC2.
RCB0753	OMC-1	Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
RCB0755	OMC-3	Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.
RCB0760	MT-8	Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.
RCB0761	505-05-01	Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.
RCB0762	MT-9	Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.
RCB0763	GI-1	Human glioma separated from gliosarcoma.
RCB0764	Fvp^(r)B350	Topoisomerase II inhibitor VP-16 resistant FM3A mutant.
RCB0768	HP50-2	Hydrogen peroxide resistant HL60-derived clone.
RCB0769	HP100-1	Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.
RCB0770	XTY	Frog (Xenopus laevis) cell line derived from subcutaneous tumor.
RCB0771	XTC-YF	Frog (Xenopus laevis) cell line derived from tadpole.
RCB0772	A6	Frog (Xenopus laevis) cell line derived from kidney.
RCB0773	A8	Frog (Xenopus laevis) cell line derived from liver.
RCB0774	EC-GI-10	Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
RCB0775	F-36P	GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.
RCB0776	F-36E	Subline of F-36P. Erythropoietin-dependent
RCB0777	HMV-II	Melanin producing. Originated from the same site of HMV-I.
RCB0778	CW-2	Colon carcinoma. CEA-positive, nude mouse-transplantable.
RCB0782	RC4	Normal rabbit cornea cells. Usually transform spontaneously during serial culture.
RCB0783	FCP-S1M	Skin fibroblasts from a familial colon polyposis patient.
RCB0784	FCP-S2H	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0785	FCP-S3H	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0786	FCP-S4H	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0787	FCP-S5H	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0788	FCP-S6H	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
RCB0789	HSQ-89	Japanese maxillary simus squamous carcinoma
RCB0792	T88-M	IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell
RCB0793	B151K12	IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.
RCB0794	2C6	Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.
RCB0795	1B2C6	Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.
RCB0796	1C3D3	Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.
RCB0797	1C3IKEI	Human embryonic pancreas-derived cell line. See RCB0794,0795,0796.
RCB0803	NBsusSR	Isolated from a patient with hiper dopaminemia andnorepinephrinemia.
RCB0804	BRF41	Zebrafish fin fibroblast. Cell growth is slow.
RCB0805	Ba/F3	IL-3 dependent pro B cell line.　Conditioned medium. Information.
RCB0806	Jurkat	Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.
RCB0808	MMAc	Human melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.
RCB0819	HMMME	Human malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.
RCB0820	HKBML	Human brain derived lymphoma. Epstein-Barr virus positive.
RCB0844	8C9	Producing anti-human CD36 MoAb.
RCB0867	3-2H3	Anti-human-myeloperoxidase MoAb producing.
RCB0868	4-2C11	Anti-human-myeloperoxidase MoAb producing.
RCB0869	9-1A11	Anti-human-myeloperoxidase MoAb producing.
RCB0870	12-1B6	Anti-human-myeloperoxidase MoAb producing.
RCB0871	LLC-GA5-CoL150	Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
RCB0872	LLC-GA5-CoL300	Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
RCB0875	Chab1KMM	Chromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.
RCB0876	RGM1	So called clear cells from rat stomach mucosa.
RCB0881	OCUB-M	Same as OCUB-1, OCUB-F.
RCB0882	OCUB-F	Same as OCUB-1, OCUB-M.
RCB0959	HH13-1	Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.
RCB0960	HH17-4	Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.
RCB0966	HGRT	Benign mature tridermal teratoma.
RCB0967	HTST	Human sacrococcygeal teratoma.
RCB0978	HIRS-BM	Mixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.
RCB0980	Sa3	Squamous carcinoma cells derived from human oral cancer.
RCB0982	ECC4	Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.
RCB0983	ECC10	Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.
RCB0985	Ae	Worm cell line established by Grace. Culturable in MGM-450-10%FBS.
RCB0987	C2C12	Said differentiate to myotubes, but need confirmation. Backup of ECA91031101 .
RCB0988	CACO-2	Human colon carcinoma. Backup of ECA86010202 . Application consideration
RCB0989	COLO 679	Melanoma from a 47 year old female. Backup of ECA87061210 .
RCB0990	CPAE	Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401 .
RCB0991	G-361	Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401 .
RCB0992	HOS	Sensitive to further transformation with both virus and chemicals. Backup of ECA87070202 .
RCB0993	IEC 6	Rat small intestine epithelial cells. Backup of ECA88071401 .
RCB0995	MDCK	Canine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903 .
RCB0996	Mv.1.Lu(NBL-7)	Aleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses.Back up culture of ECA88050503 .
RCB0998	117-13	Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell
RCB0999	MKN7	c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
RCB1001	MKN45	Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.
RCB1002	MKN74	Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.
RCB1003	MKN1	Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
RCB1005	KP4	Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
RCB1006	KP4-1	Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1007	KP4-2	Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1008	KP4-3	Pancreatic ductal cell carcinoma. PTHrP producing.
RCB1009	ECC12	Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. Application consideration
RCB1010	HOEF	Endometrium-derived fibroblasts.
RCB1011	H-AE-IV	Anencephalous embryonic fibroblast.
RCB1012	T3M-5	G-CSF producing thyroidal squamous carcinoma.
RCB1015	T3M-1 Clone2	G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.
RCB1017	T3M-1 Cl-10	G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.
RCB1018	T3M-3	Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.
RCB1020	T3M-10	Lung large cell carcinoma producing CSF. Cell growth is slow.
RCB1021	T3M-4	Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.
RCB1022	T3M-11	Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.
RCB1024	IMR-90-SV	SV40 transformed human lung fibroblast.
RCB1025	RTH33	SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.
RCB1026	GM95	Glucosylceramide synthetase-deficient B16 melanoma mutant.
RCB1027	MEB4	Not expressing melanoma antigen. Control for GM-95 cell line.
RCB1032	NOS-1	Osteoid producing in vitro and in nude mice. Cell growth is slow.
RCB1033	NOS-2	Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.
RCB1034	CJM	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1035	CJM Cl4	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1036	CJM Cl5	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1037	CJM Cl6	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1038	CJM Cl7	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1039	CJM Cl8	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
RCB1062	LMSU	Human cell line derived from lymph node metastasis of gastric cancer.
RCB1088	ψCRIP-P131	High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.
RCB1089	ψCRIP-MFGmGM-CSF	Producer of MoMLV-derived retrovirus including mouse GM-CSF cDNA
RCB1090	ψCRIP-MFGmIL-1α	High-titer producer of MoMLV-derived retrovirus including mouse IL-1alpha cDNA.
RCB1091	ψCRIP-MFGmIL-1RA	High-titer producer of MoMLV-derived retrovirus including mouse IL-1 receptor antagonist cDNA
RCB1092	ψCRIP-MFGmIL-2	High-titer producer of MoMLV-derived retrovirus including mouse IL-2 cDNA
RCB1093	ψCRIP-MFGmIL-3	Producer of MoMLV-derived retrovirus including mouse IL-3 cDNA
RCB1094	ψCRIP-MFGmIL-4	Producer of MoMLV-derived retrovirus including mouse IL-4 cDNA
RCB1095	ψCRIP-MFGmIL-6	Producer of MoMLV-derived retrovirus including mouse IL-6 cDNA
RCB1096	ψCRIP-MFGmIL-7	Producer of MoMLV-derived retrovirus including mouse IL-7 cDNA
RCB1097	ψCRIP-MFGmIL-10	Producer of MoMLV-derived retrovirus including mouse IL-10 cDNA
RCB1098	ψCRIP-MFGmIL-12p40	Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p40 subunit. Refer RCB1099.
RCB1099	ψCRIP-MFGmIL-12p35	Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p35 subunit. Refer RCB1098.
RCB1100	ψCRIP-MFGmTNF-α	Producer of MoMLV-derived retrovirus including mouse TNF-alpha gene.
RCB1101	ψCRIP-MFGhTNF-α	Producer of MoMLV-derived retrovirus including human TNF-alpha cDNA.
RCB1102	ψCRIP-MFGmLT	Producer of MoMLV-derived retrovirus including mouse lymphotoxin cDNA.
RCB1103	ψCRIP-MFGmG-CSF	Producer of MoMLV-derived retrovirus including mouse G-CSF gene.
RCB1104	ψCRIP-MFGhM-CSF	Producer of MoMLV-derived retrovirus including human M-CSF gene.
RCB1105	ψCRIP-MFGmIFN-γ	High-titer producer of MoMLV-derived retrovirus including mouse IFN-gamma cDNA.
RCB1106	ψCRIP-MFGhMIF	Producer of MoMLV-derived retrovirus including human MIF cDNA.
RCB1107	ψCRIP-MFGmLIF	Producer of MoMLV-derived retrovirus including mouse leukemia inhibitory factor cDNA.
RCB1108	ψCRIP-MFGmKitLigand	Producer of MoMLV-derived retrovirus including mouse kit ligand (SCF) cDNA.
RCB1109	ψCRIP-MFGhOncost-M	Producer of MoMLV-derived retrovirus including human oncostatin M cDNA.
RCB1110	ψCRIP-MFGmB7	Producer of MoMLV-derived retrovirus including mouse B7 (CD80) cDNA.
RCB1111	ψCRIP-MFGmB7-2	Producer of MoMLV-derived retrovirus including mouse B7-2 (CD86) cDNA.
RCB1112	ψCRIP-MFGtrγIFNR	Producer of MoMLV-derived retrovirus including the trancated form of mouse IFN-gamma cDNA.
RCB1113	ψCRIP-MFGrab-IL1RA	Producer of MoMLV-derived retrovirus including rabbit IL-1 receptor antagonist cDNA.
RCB1114	ψCRIP-MFGratGM-CSF	Producer of MoMLV-derived retrovirus including rat GM-CSF cDNA.
RCB1115	ψCRIP-MFGneo	Producer of MoMLV-derived retrovirus including neo gene.
RCB1116	ψCRIP-MFGHSVtk	Producer of MoMLV-derived retrovirus including HSV thymidine kinase cDNA.
RCB1117	ψCRE-MFGts-c-src	Producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
RCB1118	ψCRIP-MFGts-c-src	High-titer producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
RCB1119	ψCRE-MFGtsT	High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
RCB1120	ψCRIP-MFGtsT	High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
RCB1124	OP9	Support hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.
RCB1125	TOM-2	Glassy cell carcinoma from cervix. Cell growth is slow.
RCB1126	MC3T3-E1	Differentiate to osteoblasts. Collagen producing.
RCB1127	MC3T3-G2/PA6	Support hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.
RCB1129	TGBC1TKB	Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration
RCB1130	TGBC2TKB	Japanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration
RCB1139	HFSKF-AE-V	Human skin fibroblasts from embryo.
RCB1142	10H-2	Anti poly(ADP-ribose) IgG3 kappa producing.
RCB1143	DA-1	IL-3 dependent mouse myeloid cells. MoLV induced.
RCB1144	DA-3	IL-3 dependent mouse myeloid cells. MoLV induced.
RCB1145	32D	IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.
RCB1148	TGBC11TKB	Japanese gastric cancer, lymph node metastated. Application consideration
RCB1151	RCC10RGB	Kidney carcinoma from a Japanese patient. Cell growth is slow.
RCB1152	Sawano	Naturally raised CDDP(cisplatin)-resistant cell line.
RCB1153	S2 (Drosophila)	Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1.
RCB1154	KGN	Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.
RCB1155	Hepa-E1	Eel hepatocyte. Application consideration
RCB1157	UV-P3U1-B8	Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.
RCB1158	B16F10/mGM	Mouse GM-CSF producing B16 melanoma.
RCB1164	MOLT-3	Human T cell leukemia, the same patient as RCB0206 MOLT-4.
RCB1165	YAC-1	Natural killer cell-sensitive mouse lymphoma.
RCB1166	KG-1	Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+
RCB1167	P-815	Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays.
RCB1168	SKW-3	Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979
RCB1169	TGBC18TKB	Papillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow. Application consideration
RCB1171	HOUFXXX	47,XX,+X-type chromosome.
RCB1174	GEM-81	Tumor cells derived from Gold Fish red pigment cells.
RCB1175	GEM-199	Tumor cells derived from Gold Fish red pigment cells.
RCB1176	GEM-218	Tumor cells derived from Gold Fish red pigment cells.
RCB1178	HuG1-PI	Stomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.
RCB1179	HuG1-N	Stomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.
RCB1180	Tanoue	B-lineage acute lymphoblastic leukemia.
RCB1181	ST	A subclone of RCB1180 Tanoue.
RCB1182	GR-ST	RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
RCB1184	Lu-165	Producing high level of anti-diuretic hormone. Application consideration
RCB1185	TT1TKB	Rectal carcinoma from a Japanese patient. Cell growth is slow. Application consideration
RCB1186	TGBC14TKB	Japanese gallbladder tumor passed through a nude mouse. Application consideration
RCB1187	TUHR3TKB	Japanese kidney carcinoma cells. RCB original. Cell growth is slow.
RCB1188	NRS-1	Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration
RCB1189	THP-1	Differentates to macrophage-like cells after treatment with phorbol ester. The variant subline (RCB2128 A-THP-1). Application consideration
RCB1190	7-TD-1	Responding to IL-6 in the bioassay.
RCB1191	5637	Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.
RCB1192	MDA-MB-453	Human breast carcinoma established from an effusion. Application consideration
RCB1193	COLO-320	Described to produce serotonin, epinephrine.
RCB1196	TGBC24TKB	Japanese gallbladder carcinoma established from metastated ascite. Application consideration
RCB1197	P2UR/K-562	Expressing P2U receptor acting in signal transduction pathway.
RCB1198	TUHR4TKB	Japanese renal carcinoma cells. Cell growth is slow.
RCB1200	MMAc·SF	Serum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit
RCB1205	Anti-PT-S1-1B7	Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.
RCB1208	Anti-PT-S1-10D6	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1209	Anti-PT-S1-8G4	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1212	Anti-PT-S1-3F10	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1214	Anti-PT-S1-4D10	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
RCB1215	Anti-PT-S23-11E6	Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.
RCB1220	Anti-PT-S2-3A12	Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
RCB1222	Anti-PT-S2-9G8	Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
RCB1223	Anti-PT-S3-7E10	Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.
RCB1229	Anti-PT-S4-7F2	Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
RCB1233	Anti-PT-S4-1H2	Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
RCB1238	Anti-FHA(2)2E9	Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
RCB1239	Anti-FHA(1)1C6	Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
RCB1240	Anti-α(1)1C6F4	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1243	Anti-α(4)11D9G5	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1244	Anti-α(5)11D10B6	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1246	Anti-α(7)7C9A10	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1247	Anti-α(8)9F3A6	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1248	Anti-α(9)12G8B11	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
RCB1250	Anti-θ(1)3H10	MoAb to Clostridium perfringens theta-toxin.
RCB1264	tsBN2	Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.
RCB1267	tsBN7	Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.
RCB1268	tsBN462	Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration
RCB1269	tsBN75	Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.
RCB1270	tsBN51	Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.
RCB1271	tsBN67	Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.
RCB1272	tsBN250	Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.
RCB1273	tsBN269	Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.
RCB1275	TUHR10TKB	Japanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.
RCB1278	MtT/E	Estrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se. Application consideration.
RCB1279	TtT/GF	Pituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.
RCB1280	TGBC50TKB	3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration
RCB1281	TGBC51TKB	3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration
RCB1282	TGBC52TKB	3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration
RCB1283	B16 melanoma	Mouse melanoma producing melanin. Application consideration
RCB1284	B16 melanoma/lacZ	Mouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.
RCB1285	3A21	Anti-ribonuclease A antibody producing.
RCB1286	ECPC-3	Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.
RCB1287	ECPC-4	Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape
RCB1290	OIH-1	Human myeloid leukemia cell line with chromosome 18 trisomy and mutation in DCC gene. Cell growth is slow. Application consideration
RCB1292	RBE	Human intrahepatic cholangiocarcinoma.Please read carefully this information before use.
RCB1293	SSP-25	Human intrahepatic cholangiocarcinoma. Please read carefully this information before use.
RCB1294	HRC-17	Hybridoma producing anti-E antigen of the human Rh blood group system
RCB1296	HNT-34	AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. Application consideration
RCB1297	HYT-1	Human acute myeloid leukemia derived cell.
RCB1303	anti-αA-crystallin	Anti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1304	anti-αB-crystallin	Anti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1305	anti-β5-crystallin	Anti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1306	anti-β6-crystallin	Anti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1307	anti-γ1-crystallin	Anti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1308	anti-δ-crystallin	Anti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
RCB1311	C3H/HeN-emb	Mouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.
RCB1312	C57BL/6J-emb	Mouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.
RCB1313	RERF-LC-KJ	Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.
RCB1316	CTB-1	Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
RCB1317	KU-SN	Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.
RCB1366	HuH-7	Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.
RCB1367	HuH-6	Hepatoblastoma. Said albumin and alpha-fetoprotein producing.
RCB1369	NBT-T1	A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.
RCB1370	NBT-T2	A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.
RCB1371	NBT-L1	A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.
RCB1372	NBT-L2a	A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.
RCB1373	NBT-L2b	A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.
RCB1374	1-8	CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1375	2-2	35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1376	2-7	A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1377	32Dcl3	Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.
RCB1378	MuSS	A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.
RCB1382	CF1TKB	Japanese cystic fibrosis fibroblast.
RCB1383	TUHR14TKB	Japanese renal carcinoma cells. Cell growth is slow.
RCB1422	L929	TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.
RCB1423	BHK-21	The parent cell line used for the temperature sensitive cell line series of BN.
RCB1425	LCAM1	Human lung cancer derived cell.
RCB1426	PMF-ko14	Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.
RCB1429	SN-512	Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.
RCB1433	TEN	So called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).
RCB1434	KE-39	Human cell line derived from gastric cancer
RCB1435	KE-97	Human cell line derived from intraperitoneal metastasis of gastric cancer
RCB1437	AW-EBV-LCL	B95-8 EB virus transformed leukemia cell line.
RCB1438	TW-EBV-LCL	B95-8 EB virus transformed (originally normal) B cell line.
RCB1440	ATN-1	Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).
RCB1444	MBHL-2	Insect cell line derived from Mamestra brassicae. Cell growth is slow.
RCB1445	MBHL-3	Insect cell line derived from Mamestra brassicae
RCB1449	C7	p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene. Cell growth is slow.
RCB1450	LM8	A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).
RCB1451	L929	Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.
RCB1456	RCR-1	Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.
RCB1460	PCM6	Human myeloma cell.
RCB1464	DT40	Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.
RCB1465	SHIP^(-) DT40	SHIP deficient DT40 cells
RCB1466	SHP1^(-) DT40	SHP1 deficient DT40 cells
RCB1467	IP3R^(-) DT40	IP3R(type1,type2,type3) deficient DT40 cells
RCB1468	Btk^(-) DT40	Btk deficient DT40 cells
RCB1469	PLC-γ2^(-) DT40	PLC-γ2 deficient DT40 cells
RCB1470	Syk^(-) DT40	Syk deficient DT40 cells
RCB1471	Lyn^(-) DT40	Lyn deficient DT40 cells
RCB1472	M	Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.
RCB1473	LYM-1	Sticky cell from lymph node. Possible to culture in DMEM medium.
RCB1474	RLC-16	Epithelial cell from rat liver. Possible to culture in DMEM medium.
RCB1477	CHO-RD	Subline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration
RCB1483	OV2944-HM-1	Lymphnode-metastatic ovarian tumor. So called HM-1 cells.
RCB1484	RLC-18	Non tumorigenic in nude mice. Possible to culture in DMEM medium.
RCB1486	JTC-19	Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .
RCB1487	MY-EBV-LCL	B95-8 EB virus transformed (originally normal) B cell line.
RCB1489	RLC-27	Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.
RCB1495	FU-RPNT-1	Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration
RCB1498	Grap^(-) DT40	Grap deficient DT40 cells
RCB1499	Grb2^(-) DT40	Grb2 deficient DT40 cells
RCB1500	Lyn^(-)/Syk^(-) DT40	Lyn and Sky deficient DT40 cells
RCB1501	SHP1^(-)/SHP2^(-) DT40	SHP1 and SHP2 deficient DT40 cells
RCB1502	SHP2^(-) DT40	SHP2 deficient DT40 cells
RCB1503	Shc^(-) DT40	Shc deficient DT40 cells
RCB1506	clone YP1N25	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible. Cell growth is slow.
RCB1507	clone YP1N27	A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.
RCB1508	clone 76	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.
RCB1509	clone 64	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.
RCB1510	BLNK^(-) DT40	BLNK deficient DT40 cells
RCB1512	MH7A	Rheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.
RCB1513	HOMM	Melanoma cells with melanin-granules. Cell growth is slow.
RCB1514	HOCE	Japanese choriocarcinoma cell line. Cell growth is slow. Application consideration
RCB1517	A-6(ES derived)	Mouse ES ( AES0001 H-1 ) cell derived cell, useful for study of hematopoiesis.
RCB1518	SS-A3-1	F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.
RCB1520	JHOC-5	Clear cell adenocarcinoma. Said CA125, CA72-4 producing. Application consideration
RCB1521	JHOS-2	Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. Application consideration
RCB1525	HeLa.S3	= RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.
RCB1528	CCP-2	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1530	CCP-7	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1531	CCP-8	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
RCB1534	MLC-1-B	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.
RCB1535	MLC-2-4	Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
RCB1536	MLC-6	Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.
RCB1537	MLC-7	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.
RCB1538	32Dcl3	Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.
RCB1539	P19.CL6	Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.
RCB1541	HFL9t	47, +del(9)(q12) chromosome, the same patient as RCB1542.
RCB1542	HFSK9t	47, +del(9)(q12) chromosome, the same patient as RCB1541.
RCB1543	JHTKI-col-L	B lymphocytes isolated from a colon adenocarcinoma.
RCB1544	JHUAS-1	Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow. Application consideration
RCB1545	JHUAS-2-L	B lymphocyte isolated from Japanese adenosquamous carcinoma.
RCB1546	JHOS-3	Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. Application consideration
RCB1547	JHUCS-1	Japanese uterine carcinosarcoma. Nude mouse transplantable. Application consideration
RCB1548	JHUEM-1	Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing. Application consideration
RCB1549	YSCCC	Human cell line derived from cholangiocellular carcinoma. Cell growth is slow.
RCB1550	HL-60-R2	Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.
RCB1551	JHUEM-2	Japanese endometrioid adenocarcinoma. Application consideration
RCB1552	JHUEM-3	Human uterus endometrioid adenocarcinoma cell line. Application consideration
RCB1555	F9	Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.
RCB1558	JHUS-nk1	Human uterus squamous cell carcinoma cell line. Application consideration
RCB1560	PWS-Yamaguchi	Prader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.
RCB1561	RML-Yoshi	Severe insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.
RCB1564	ψCRIP-RxnZ	Subline of ψCRIP that produce virus to express LacZ possessing nuclear localization signal.
RCB1572	ψCRIP-hBax-i-hCD25-CS	Retrovirus producer. Produce virus to express human Bax protein.
RCB1573	ψCRIP-ATR-bsr	Cell line producing retrovirus to express angiotensin receptor.
RCB1574	ψCRIP-RxhCD82	Cell line producing retrovirus to express the human CD82.
RCB1575	ψCRIP-Rx-crmA-bsr	Cell line producing retrovirus to express the anti-apoptotic crmA.
RCB1576	ψCRIP-Rx-ETBR-bsr	Cell line producing retrovirus to express the human endothelin receptor.
RCB1577	ψCRIP-mPCNF1-bsr	Cell line producing retrovirus to express the mouse calcineurin.
RCB1579	ψCRIP-MFG-Z	Cell line producing retrovirus to express lac Z.
RCB1580	ψCRIP-MFG-T37	Cell line producing retrovirus to express SV40 large T antigen.
RCB1581	ψCRIP-MSHR	Cell line producing retrovirus to express human MSH receptor.
RCB1582	ψCRIP-NCre	Cell line producing retrovirus to express Cre recombinase.
RCB1583	ψCRIP-hp53-bsr	Cell line producing retrovirus to express human p53 and blasticidin S deaminase gene.
RCB1584	ψCRIP-RxBcl-XL-i-bsr	Cell line producing retrovirus to express human Bcl-xL and blasticidin S deaminase gene.
RCB1585	ψCRIP-RxhFAS-i-CD80	Cell line producing retrovirus to express human FAS and human CD80.
RCB1587	ψCRIP-RxhSecR-bsr	Cell line producing retrovirus to express human secretin receptor and blasticidin S deaminase gene.
RCB1588	ψCRIP-hSSR-bsr	Cell line producing retrovirus to express human somatostatin receptor and blasticidin S deaminase gene.
RCB1589	ψCRIP-RxmPCNT1-i-bsr	Cell line producing retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase gene.
RCB1590	ψCRIP-RxhVIPR-bsr	Cell line producing retrovirus to express human VIP receptor and blasticidin S deaminase gene.
RCB1591	SRA 01/04	alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.
RCB1593	OS3	ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes
RCB1597	KKC	Mouse T cell line transformed by Gross leukemia virus.
RCB1598	NCKA	Mouse T cell line transformed by Gross leukemia virus.
RCB1600	KKF	Mouse T cell line transformed by Gross leukemia virus.
RCB1601	KKB	Mouse T cell line transformed by Gross leukemia virus.
RCB1604	DHA3-1	Mouse T cell hybridoma expressing double HA-tag alone.
RCB1605	DHA3-26	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1606	DMyc3-45	Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .
RCB1607	DHA9-3	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
RCB1608	DHA9-13	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
RCB1609	DHA9-15	Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1610	DMyc9-36	Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
RCB1611	M4	Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.
RCB1613	HFL-AE-VI	Human lung fibroblasts derived from anencephalous embryo.
RCB1615	HFSKF-AE-VII	Human skin fibroblasts derived from anencephalous embryo. RCB1617 and RCB1618 are derived from the same embryo.
RCB1617	HFL-AE-VII	Human lung fibroblasts derived from anencephalous embryo. RCB1615 and RCB1618 are derived from the same embryo.
RCB1618	HFLI-AE-VII	Human liver fibroblasts derived from anencephalous embryo. RCB1615 and RCB1617 are derived from the same embryo.
RCB1620	ΔDNAPK-DT40	DNA PK gene deleted DT40 (chicken B cell line).
RCB1621	ΔKu70-DT40	Ku70 gene deleted DT40 (chicken B cell line).
RCB1622	ΔRad51B-DT40	Rad51B gene deleted DT40 (chicken B cell line).
RCB1623	ΔRad51C-DT40	Rad51C gene deleted DT40 (chicken B cell line).
RCB1624	ΔRad51D-DT40	Rad51D gene deleted DT40 (chicken B cell line).
RCB1625	ΔXRCC2-DT40	XRCC2 gene deleted DT40 (chicken B cell line).
RCB1626	ΔXRCC3-DT40	XRCC3 gene deleted DT40 (chicken B cell line).
RCB1627	ΔRad52-DT40	Rad52 gene deleted DT40 (chicken B cell line).
RCB1628	ΔRad54-DT40	Rad54 gene deleted DT40 (chicken B cell line).
RCB1629	ΔMre11-DT40(#190)	Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.
RCB1630	ΔMre11-DT40(#194)	Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.
RCB1631	ΔRad51+hRad51-DT40	Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).
RCB1632	ΔKu70ΔRad54B-DT40	Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).
RCB1633	ΔMre11ΔKu70-DT40	Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1634	ΔRad54ΔRad54B-DT40	Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).
RCB1635	K-562	Human CML derived cell line. Deposited directly from the institution that has established this cell.
RCB1637	293	Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.
RCB1638	Hepa 1-6	Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.
RCB1639	LoVo	CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.
RCB1640	DAUDI	Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.
RCB1641	EL4	9,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.
RCB1642	3T3 Swiss Albino	Contact inhibition. Buck up culture of ECA2854.
RCB1644	BeWo	It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.
RCB1645	Y79	Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.
RCB1647	RAJI	Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.
RCB1648	Hep G2	hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870.Information
RCB1649	ΔAtm-DT40	ATM gene deleted DT40 (chicken B cells).
RCB1650	ΔAtmΔKu70-DT40	ATM and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1651	ΔAtmΔRad54+hRad54-DT40	ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
RCB1652	G1MF285D	Hybridoma that produce anti-human G1MF (allotype of IgG1) antibody.
RCB1668	293/CrmA	293 cell line expressing the caspase-inhibiting CrmA gene
RCB1672	ΔRad54+hRad54-DT40	Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
RCB1675	Cbl^(-) DT40	Cbl deficient DT40 cells
RCB1676	JHOM-1	Human ovary mucinous adenocarcinoma cell line. Application consideration
RCB1677	JHUEM-7	Human uterus endometrial adenocarcinoma cell line. Application consideration
RCB1678	JHOS-4	Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. Application consideration
RCB1680	TUHR25TKB	Human cell line derived from kidney cancer.
RCB1681	GS-HepG2	A subline of HepG2. Expressing abundant glutamine synthetase. Information
RCB1682	JHOM-2B	Human ovary mucinous tubular adenocarcinoma cell line. Application consideration
RCB1687	ΔRad54ΔKu70-DT40	Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).
RCB1688	JHOC-7	Human ovary clear cell carcinoma cell line. Application consideration
RCB1690	CPN4B	Cell line derived from embryo of Cynops pyrrhogaster. Cell growth is slow.
RCB1691	Tpit/F1	Folicular dendritic cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.
RCB1692	Tpit/E	Immature pituitary cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse. PMID: 24881870
RCB1695	RMS-YM	Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.
RCB1696	SPB-1	Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.
RCB1697	SPB-1/cLCB1	SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.
RCB1698	LY-B	Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.
RCB1699	LY-B/cLCB1	LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.
RCB1701	MY	Human cell line derived from p180-BCR-ABL dependent leukemia.
RCB1702	SLVL	Human cell line derived from splenic B cell lymphoma.
RCB1704	BLNK^(-)/Syk^(-) DT40	BLNK and Syk deficient DT40 cells
RCB1705	JHCA-ov	Human colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Application consideration
RCB1706	JHCOLOYI	Human cell line derived from rectal cancer. Application consideration
RCB1708	JHTSK-col-L	Human B cell-like cell line derived from colon adenocarcinoma tisuue.
RCB1709	GE1	Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration
RCB1716	BCAP^(-) DT40	BCAP deficient DT40 cells
RCB1717	IP3R type1^(-)/2^(-) DT40	IP3R type1 and IP3R type2 deficient DT40 cells
RCB1718	IP3R type1^(-)/3^(-) DT40	IP3R type1 and IP3R type3 deficient DT40 cells
RCB1719	IP3R type2^(-)/3^(-) DT40	IP3R type2and IP3R type3 deficient DT40
RCB1721	JHUCS-3	Human cervical cancer cell line. Application consideration
RCB1723	JHOC-8	Human ovary clear cell carcinoma cell line. Application consideration
RCB1724	JHSK-rec	Human rectal cancer cell line. Application consideration
RCB1728	Hpr-4	H2O2 resistant Chinese Hamster V79 cells
RCB1731	TM-31	Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
RCB1734	LAH3	Melanophore derived cell line. Derived from Rana porosa brevipoda (albino). Cell growth is slow.
RCB1741	NHOS	Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.
RCB1747	ΔNBS1-DT40	Subline of DT40 (chicken B cell line), lacking Nbs1 expression.
RCB1749	ΔDinB-DT40	Subline of DT40 cell line, lacking DinB expression.
RCB1750	ΔRad18-DT40	Subline of DT40 cell line, lacking Rad18 expression.
RCB1752	BS-SHI-4M	Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.
RCB1753	KMY-J	Meningioma derived cell line. Derived from rat F344.
RCB1754	KMY-1	Subline of KMY-J. Fibroblast-like
RCB1755	KMY-2	Subline of KMY-J. Epithelial-like
RCB1756	KMY-3	Subline of KMY-J. Polyploidy
RCB1757	HS-P	Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.
RCB1759	ΔDNAPKΔKu70-DT40	Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.
RCB1764	ΔRev3-DT40	Subline of DT40 cell line, lacking Rev3 expression.
RCB1766	ΔligIV-DT40	Subline of DT40 cell line, lacking ligase IV expression.
RCB1767	ΔRad52ΔXRCC3-DT40	Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.
RCB1768	ΔXRCC3-cond1-DT40	Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
RCB1769	ΔXRCC3-cond2-DT40	Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
RCB1770	XRCC3+/–DT40	Subline of DT40 cell line, lacking XRCC3 only in one allele.
RCB1771	Lu-24	Human cell line derived from lung cancer. Oat cell type. Application consideration
RCB1772	Lu-141	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1773	Lu-143	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1785	Lu-138	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
RCB1788	AT805	Mouse teratoma-derived cell line. Parent cell line of ATDC5.
RCB1790	P19C6	Embryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.
RCB1791	PCC3/A/1	Mouse teratoma-derived cell line.
RCB1792	SIL-6/1	Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.
RCB1794	ΔRad18ΔXPA-DT40	Subline of DT40 cell line, lacking both of Rad18 and XPA expression.
RCB1795	ΔRad18ΔDinB-DT40	Subline of DT40 cell line, lacking both of Rad18 and DinB expression.
RCB1797	BP7(R80)	Rat renal tumor derived cell line.
RCB1798	BP11(R2)	Rat (Wistar) cell line derived from renal (kidney) tumor.
RCB1799	BP11(R100)	Rat (Wistar) cell line derived from renal (kidney) tumor.
RCB1800	BP13(R2)	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1801	BP13(R100)	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1802	BP26(R2)	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1803	BP26(R80)	Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.
RCB1804	BP30(R2)	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1805	BP30(R100)	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1806	BP36B(R2)	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
RCB1807	BP36B(R100)	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
RCB1809	Vav3^(-) DT40	Vav3 deficient DT40 cells
RCB1810	PI3Kp110α^(-) DT40	PI3Kp110α deficient DT40 cells
RCB1811	ΔBLM-DT40	Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.
RCB1812	ΔWRN-DT40	Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.
RCB1813	ΔWRNΔBLM-DT40	Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.
RCB1814	ΔDinBΔXPA-DT40	Subline of DT40 cell line, lacking both of DinB and XPA expression.
RCB1817	DT40(v-myb^+)WT	A subline of avian cell line, DT40, expressing v-myb exogenously.
RCB1818	DT40(v-myb^+)Δpolβ	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.
RCB1819	DT40(v-myb^+)Δpolλ	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.
RCB1820	DT40(v-myb^+)Δpolλβ	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.
RCB1821	CHO-FLAG-hBLT1	Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).
RCB1822	CHO-HA-hBLT2	Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).
RCB1823	CHO·1F8	Subline of CHO-K1 that expresses human platelet activating factor receptor.
RCB1824	TRP1^(-) DT40	TRP1 deficient DT40
RCB1829	SC-1	Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
RCB1830	Rat-1	Rat fibroblast-like cell line that can be transformed by oncogenes.
RCB1831	XC	Cell line for titration of murine leukemia virus.
RCB1832	THK	SV40 transformed hamster cell line. Fibroblast-like cells.
RCB1833	Mink	Lung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.
RCB1834	S+L-Mink	Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.
RCB1835	Sirc	Fibroblast-like cell line derived from rabbit.
RCB1836	Grb2^(-)/Grap^(-) DT40	Grb2and Grap deficient DT40 cells
RCB1837	MVP1	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1838	MVP25	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1839	MVP47	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1840	MVP49	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1841	MVP51	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
RCB1845	ΔUbc9+cUbc9-DT40	Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously
RCB1846	HSC-F	T cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1847	ES-8040 20-2	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1848	ES-8047 2-1	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1849	C-8049	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1850	C-8052	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
RCB1851	DT40 Cre1	A subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).
RCB1853	MSH6-1-[ClX3.16]DT40	A subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).
RCB1854	HSP-239	T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1855	HSP-250	T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1856	TX-7F (hybridoma)	Hybridoma producing a monoclonal antibody against tetrodotoxin.
RCB1857	DA-3 (hybridoma)	Hybridoma producing a monoclonal antibody against domoic acid.
RCB1858	GT-13A (hybridoma)	Hybridoma producing a monoclonal antibody against gonyautoxin.
RCB1859	MDBK-NST	Bovine kidney-derived epithelial cell line. FBS independent for culture.
RCB1860	BLNK^(-)Grb2^(-)DT40	BLNK and Grb2 deficient DT40 cells
RCB1861	T-23	Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
RCB1862	NIH3T3-3-4	Subclone of NIH3T3
RCB1863	GRP1^(-)DT40	Ras GRP1 deficient DT40 cells
RCB1864	GRP3^(-)DT40	Subline of DT40 cell line, lacking RasGRP3 expression.
RCB1865	GRP1^(-)/GRP3^(-)DT40	Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.
RCB1866	Sos1^(-)DT40	Subline of DT40 cell line, lacking Sos1 expression.
RCB1867	Sos2^(-)DT40	Subline of DT40 cell line, lacking Sos2 expression.
RCB1868	Sos1^(-)/Sos2^(-)DT40	Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.
RCB1869	LY-A	Subline of CHO-K1 cell line in which trafficking of ceramide is deficient
RCB1870	LY-A/hCERT	Subline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered
RCB1871	TL-1	Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607(Deposited from Tohoku Univ.). Application consideration
RCB1872	A431	Human cell line derivd from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).
RCB1873	JTK-LCL	Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).
RCB1874	KOIA-LCL	EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).
RCB1875	XPL 5	Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309(Deposited from Tohoku Univ.).
RCB1876	211-LCL-MUC1	Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615 (Deposited from Tohoku Univ.).
RCB1878	RPMI1788	IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).
RCB1879	PEER	Human T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).
RCB1881	TL-Mor	Human derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).
RCB1882	BALL-1	Human cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).
RCB1884	H-111-TC	Human cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.). Cell growth is slow.
RCB1886	Hep G2	Human cell line derived from hepatocyte carcinoma. TKG0205 (Deposited from Tohoku Univ.). Information
RCB1889	HEp-2	Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination).TKG0403 (Deposited from Tohoku Univ.).
RCB1890	MG-63	Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN.TKG0294 (Deposited from Tohoku Univ.).
RCB1891	HeLa TG	A subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).
RCB1892	SKG-IIIa	Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).
RCB1894	TE-1	Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).
RCB1896	TN-2	Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).
RCB1897	K562	Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes.TKG0210 (Deposited from Tohoku Univ.).
RCB1898	K562/Adr	Subline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).
RCB1900	Lu99	Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).
RCB1901	PK-59	Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).
RCB1902	HSC-4	Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
RCB1903	OVK18	Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
RCB1904	MCF7	Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
RCB1905	Sq-1	Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration
RCB1907	TKKK	Human cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).
RCB1909	8305C	Human thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).
RCB1911	CCD-IC	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.
RCB1912	CNT	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.
RCB1913	PST-S2	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.
RCB1914	BBWV-22K3-9B	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1915	BBWV-22K5-12A	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1916	BBWV-22K6-2A	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
RCB1918	J#176-3.2	Hybridoma producing a monoclonal antibody against mouse JDP2.
RCB1919	J#214.2-2	Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.
RCB1920	J#249.1-1	Hybridoma producing a monoclonal antibody against mouse JDP2.
RCB1921	NRG	Mouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.
RCB1922	1C7	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB1923	13D10	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB1924	h1c	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
RCB1925	WA-mFib	Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.
RCB1926	OT11	RBP-J deficient mouse fibroblasts
RCB1927	OT13	Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)
RCB1928	KG-1a	Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).
RCB1932	T2	Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).
RCB1933	NALM-6	Human cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).
RCB1934	HUT78	Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375(Deposited from Tohoku Univ.).
RCB1935	HPB-ALL	Human cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).
RCB1936	MOLT-4F	Human T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).
RCB1938	P30/OHK	Human cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).
RCB1939	NUGC-4	Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
RCB1940	SH-10-TC	Human cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).
RCB1941	Li-7	Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing.TKG0368 (Deposited from Tohoku Univ.).
RCB1942	HuH-7	Human cell line derived from hepatoma. TKG0206 (Deposited from Tohoku Univ.).
RCB1943	HuH-28	Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).
RCB1945	HSC-2	Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
RCB1947	Ca Ski	Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).
RCB1949	TE-5	Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
RCB1950	TE-6	Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).
RCB1951	TE-15	Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).
RCB1952	SCCH-26	Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).
RCB1953	NB-1	Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486(Deposited from Tohoku Univ.).
RCB1954	T98G	Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).
RCB1955	KMST-6	Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic.TKG0482 (Deposited from Tohoku Univ.).
RCB1960	HuCCT1	Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).
RCB1963	VMRC-RCW	Human renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).
RCB1965	EBC-1	Human lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).
RCB1966	S1	Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration
RCB1967	LU65	Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).
RCB1970	LK-2	Human lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).
RCB1971	Lu99B	Human lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).
RCB1972	PK-1	Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239(Deposited from Tohoku Univ.).
RCB1973	PK-45H	Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).
RCB1974	SAS	Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).
RCB1975	HSC-3	Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).
RCB1976	Ca9-22	Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.).
RCB1980	CCRF-CEM	Human cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).
RCB1981	HD-Mar2	Human cell line derived from Hodgkin's lymphoma. TKG0198 (Deposited from Tohoku Univ.).
RCB1988	TE-9	Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
RCB1990	KUSA-H1	Mouse bone marrow-derived stromal cells.
RCB1991	KUSA-O	Mouse multipotent mesenchymal cells. Derived from bone marrow.
RCB1992	UV♂1d	Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.
RCB1993	UV♀1A	Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.
RCB1994	UV♀2	Mouse vascular endothelial cell line. Transformed by ultraviolet.
RCB1995	UV·BAL-1.1	Mouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1996	UV·BAL-2.1D	Mouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1997	UV·B6-1.1	Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.
RCB1998	UV·B6-2.1A	Mouse skin derived cell line. Induced by ultra-violet irradiation.
RCB1999	UV·B6-4.1	Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.
RCB2000	UV·B6-5.1	Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.
RCB2013	GMR3	Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).
RCB2014	GMB7	Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).
RCB2015	GMR8	Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).
RCB2016	AMR19	Hybridoma producing a monoclonal antibody against ganglioside lactones.
RCB2021	GGR41	Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.
RCB2024	UV·BAL-3.3	Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)
RCB2025	UV·BAL-5.4G	Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)
RCB2026	UV·BAL-6.1E	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2027	UV·BAL-7.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2028	UV·BAL-8.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2029	UV·BAL-8.1C	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2030	UV·BAL-12.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2031	UV·BAL-13.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2032	UV·BAL-14.2	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2033	UV·BAL-15.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2034	UV·BAL-16.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2035	UV·BAL-17.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2036	UV·BAL-18.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2037	NGR54	Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.
RCB2039	NMR52	Hybridoma producing a monoclonal antibody against nLc4Cer.
RCB2040	NGR50	Hybridoma producing a monoclonal antibody against SGPG.
RCB2041	AMR20	Hybridoma producing a monoclonal antibody against GalCer.
RCB2042	AGB43	Hybridoma producing a monoclonal antibody against Sulfatide.
RCB2046	BMR26	Hybridoma producing a monoclonal antibody against Globoside.
RCB2048	OMB4	Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.
RCB2049	OMR5	Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.
RCB2050	OMR6	Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.
RCB2053	UV·C3H-3.3	Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.
RCB2056	UV·C3H-8.2	Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.
RCB2057	UV·BAL-19.1A	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2058	UV·BAL-20.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2059	UV·BAL-21.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2060	UV·BAL-23.1	Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
RCB2061	UV·C3B6-1.1	Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2062	UV·C3B6-1.1C	Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2065	UV·CB6-2.1F	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2066	UV·CB6-3.4B	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2067	UV·CB6-4.1D	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2068	UV·CB6-4.1F	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2070	UV·CB6-5.2	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2071	UV·CB6-5.2B	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2072	UV·CB6-6.1	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2073	UV·CB6-6.1B	Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
RCB2074	UV·CC3-11.1	Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.
RCB2076	Has	Chinese hamster cell line. Epithelial-like adherent cells.
RCB2078	FU-RPNT-2	Human primitive neuroectodermal tumor cell line derived from kidney.
RCB2081	KUSA-A1	Mesenchymal stem cell line derived from C3H/He mouse strain.
RCB2082	103-LCL	Human B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).
RCB2083	141-LCL	Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient.TKG0611 (Deposited from Tohoku Univ.).
RCB2084	TALL-1	Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
RCB2088	Kato III	Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).
RCB2092	87-5	Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).
RCB2093	II-18	Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).
RCB2094	MIA Paca2	Human cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).
RCB2095	PANC-1	Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).
RCB2097	TE-4	Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0255 (Deposited from Tohoku Univ.).
RCB2098	TE-8	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).
RCB2099	TE-10	Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0261 (Deposited from Tohoku Univ.).
RCB2100	TE-11	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).
RCB2101	TE-14	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).
RCB2102	HO-1-u-1	Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).
RCB2103	8505C	Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma.TKG0439 (Deposited from Tohoku Univ.).
RCB2104	HuO-3N1	Human cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).
RCB2105	D98-AH2	Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).
RCB2106	ME-180	Human cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).
RCB2107	TN-1	Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).
RCB2108	NH-12	Human cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).
RCB2109	NH-6	Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).
RCB2110	YKG1	Human cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).
RCB2111	K562/Vin	Subline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).
RCB2112	KUM4	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2113	KUM6	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2114	KUM7	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2115	KUM9	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2116	TSt-4	Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.
RCB2117	TSt-4/G	Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.
RCB2118	TSt-4/G-DLL1	Original murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.
RCB2119	TSt-4/N	Original murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.
RCB2120	TSt-4/N-DLL1	Original murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.
RCB2125	BmN4-DR	Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
RCB2126	BmN4-IR	Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
RCB2127	COLO205	Human cell line derived from colon cancer. Derived from ascites metastasis. Cell growth is slow.TKG0457 (Deposited from Tohoku Univ.).
RCB2128	A-THP-1	Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296 (Deposited from Tohoku Univ.).
RCB2133	S2	Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration
RCB2134	86-2	Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).
RCB2135	NIH:OVCAR-3	Human cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).
RCB2136	YST-1	Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
RCB2138	KLM-1	Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient.TKG0490 (Deposited from Tohoku Univ.).
RCB2141	PK-45P	Human cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient.TKG0493 (Deposited from Tohoku Univ.).
RCB2143	DU145	Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).
RCB2144	LNCap.FGC	Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis.TKG0603 (Deposited from Tohoku Univ.).
RCB2145	PC-3	Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).
RCB2146	WERI-Rb-1	Human cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).
RCB2147	KUM3	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2148	KOP	Mouse fibroblast-like cell line lacking p38 MAP kinase expression.
RCB2149	RKOP	Subline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.
RCB2150	EKOP	Subline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.
RCB2151	ZKOP	Subline of KOP cell line. Zeocin-resistant.
RCB2163	UE6E7-16	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.
RCB2202	293T	Human cell line expressing SV40 large T antigen abundantly.
RCB2203	TFS-2	Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
RCB2204	TFS-4	Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
RCB2205	NCC-RbC-39	Human retinoblastoma cell line.
RCB2206	NCC-RbC-51	Human retinoblastoma cell line derived from cervical lymph node metastasis.
RCB2208	NCC-RbC-54	Human cell line derived from retinoblastoma.
RCB2212	NCC-RbC-59	Human cell line derived from retinoblastoma. Cell growth is slow.
RCB2213	NCC-RbC-60	Human cell line derived from retinoblastoma.
RCB2214	NCC-RbC-67	Human cell line derived from retinoblastoma.
RCB2217	NCC-RbC-83	Human cell line derived from retinoblastoma.
RCB2218	NCC-RbC-92	Human cell line derived from retinoblastoma.
RCB2219	NCC-RbC-T1	Human cell line derived from retinoblastoma.
RCB2223	NCC-OvC-K119	Human cell line derived from ovarian cancer.
RCB2224	NCC-StC-K140	Human cell line derived from stomach cancer.
RCB2225	JHUEM-14	Human cell line derived from uterus cancer. Endometrioid adenocarcinoma. Application consideration
RCB2226	JHOC-9	Human cell line derived from ovary cancer. Clear cell carcinoma. Application consideration
RCB2227	JMSU1	Human cell line derived from urinary bladder carcinoma. Derived from ascites.
RCB2229	HS-Os-1	Human cell line derived from osteosarcoma.
RCB2230	HS-Sch-2	Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).
RCB2231	HS-SY-II	Human cell line derived from synovial sarcoma. Application consideration
RCB2233	HE12	Human fibroblast-like cells derived from embryo. Not immortalized. Application consideration
RCB2234	HE13	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2237	HE16	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2238	HE18	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2239	HE19	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2240	HE21	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2241	HE22	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2244	HE27	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2245	HE28	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2246	HE29	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2247	HE30	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2248	HE31	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2249	HE32	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2250	HE33	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2251	HE34	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2253	HKb20	Subline of HEK293 cell line, expressing BtR175b (Cry 1Aa receptor).
RCB2254	HE36	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2256	HE37	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2257	HE38	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2258	HE39	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2259	HE40	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2260	HE41	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2261	HE42	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2262	HE46	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2263	HE47	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2264	HE48	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2265	HE49	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2266	HE50	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2267	HE51	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2268	HE52	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2269	HE53	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2270	HE54	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2271	HE55	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2273	HE57	Human fibroblast-like cells derived from embryo. Not immortalized.
RCB2277	GSS	Human gastric cancer cell line derived from metastasis at liver.
RCB2278	GSU	Human cell line derived from gastric cancer. Established from the cells in ascites.
RCB2279	WA-hT	Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.
RCB2280	HCE-T	SV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium.
RCB2281	T3M-12	Human lung small cell carcinoma cell line. ADH producing.
RCB2282	701-LCL	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610(Deposited from Tohoku Univ.).
RCB2283	277-LCL	Human B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).
RCB2286	XPL 17	Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).
RCB2287	XPL 20	Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).
RCB2288	211-LCL	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616(Deposited from Tohoku Univ.).
RCB2292	ACC-MESO-1	Human malignant pleural mesothelioma cell line.
RCB2293	ACC-MESO-4	Human malignant pleural mesothelioma cell line.
RCB2295	KUM10	Mouse mesenchymal cell line derived from bone marrow.　C57/B6.
RCB2296	CARMA1^(-)DT40	Subline of DT40 cell line, lacking CARMA1 expression.
RCB2297	PKCβ^(-)DT40	Subline of DT40 cell line, lacking PKC-β expression.
RCB2298	TAK1^(-)DT40	Subline of DT40 cell line, lacking TAK1 expression.
RCB2299	RMC-1	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2300	RMC-2	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2301	RMC-3	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2302	RMC-6	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2303	RMC-11	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2304	RMC-17	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
RCB2305	MIH5(GIT)	Hybridoma producing a monoclonal antibody against mouse B7-H1.
RCB2306	PC3.1	Hybridoma producing monoclonal antibody against latexin.
RCB2307	T1.7	Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.
RCB2308	802C11	Hybridoma producing monoclonal antibody against MuSc.
RCB2309	JFP-J1	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2310	JFP-J5	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2311	JFP-K2	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
RCB2312	859H5	Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.
RCB2313	884F11	Hybridoma producing monoclonal antibody against mouse apolipoprotein E.
RCB2314	F9/LM10	Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
RCB2315	F9/LM(1+10)	Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
RCB2316	AB1	Hybridoma producing monoclonal antibody against GD1b gangliosides.
RCB2317	AC1	Hybridoma producing monoclonal antibody against GD1c gangliosides.
RCB2318	P19.CL6	Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.
RCB2322	KUM5	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2323	9-15C	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
RCB2324	MIH5(RPMI)	Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.
RCB2326	CHO-AA8	A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.
RCB2327	EM-9	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.
RCB2328	irs1SF	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.
RCB2329	V-3	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.
RCB2330	CHO-K1	Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.
RCB2331	XR-1	A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.
RCB2332	V79-4	A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
RCB2335	V-E5	X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.
RCB2336	V-G8	A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.
RCB2337	V79B	A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
RCB2338	XR-V9B-4	A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
RCB2339	XR-V15B	A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
RCB2341	NCR-G1	Human cell line derived from embryonal carcinoma of testis.
RCB2342	NCR-G2	Human cell line derived from embryonal carcinoma of testis.
RCB2343	NCR-G3	Human cell line derived from embryonal carcinoma of testis.Application consideration
RCB2344	NCR-G4	Human cell line derived from embryonal carcinoma of testis.
RCB2345	EEB	Human cell line derived from erythroblastic leukemia.
RCB2346	NMFH-1	Human cell line derived from myxofibrosarcoma.
RCB2347	NMS-2	Human cell line derived from malignant peripheral nerve sheath tumor.
RCB2348	NOS-10	Human cell line derived from osteosarcoma.
RCB2351	OGU1	Human cell line derived from primary effusion lymphoma (PEL). Application consideration
RCB2352	633	Human lung cancer cell line expressing capsid protein of human adenovirus.
RCB2354	293gp	Retroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.
RCB2355	HeLa CD4+Clone1022	A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.
RCB2356	HeLa-CD4-LTR-β-gal	A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.
RCB2358	HLtat	A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.
RCB2360	HS-ES-2M	Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.
RCB2361	HS-ES-2R	Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.
RCB2362	HS-PSS	Human cell line derived from malignant peripheral nerve sheath tumor.
RCB2364	HS-ES-1	Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.
RCB2365	JHONA	Human cell line derived from ovarian squamous cell cancer. Application consideration
RCB2367	KT01	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
RCB2368	KT02	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
RCB2369	KT03	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
RCB2372	KT06	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
RCB2375	KT09	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2376	KT10	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2377	KT11	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2378	KT12	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
RCB2379	KT13	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.
RCB2380	KT14	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.
RCB2381	KT16	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2382	KT17	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2383	KT18	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
RCB2386	KT21	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.
RCB2388	KT23	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.
RCB2389	KT26	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.
RCB2390	KT27	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.
RCB2392	KT29	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
RCB2393	KT30	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
RCB2395	KT32	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.
RCB2400	KT54	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.
RCB2402	STIM1^(-)DT40	Subline of DT40 cell line, lacking STIM1 expression.
RCB2403	MG6	Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.
RCB2530	A172	Human cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).
RCB2531	CB-3512	Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305(Deposited from Tohoku Univ.).
RCB2532	HuO 9N2 (O9N2)	Human cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).
RCB2534	M-MOK	Human cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).
RCB2535	OVK18#102	Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357(Deposited from Tohoku Univ.).
RCB2536	T24	Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).
RCB2537	TFK-1	Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).
RCB2539	XPL 19	Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).
RCB2540	XPL 24	Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).
RCB2541	141-LCL-MUC1	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).
RCB2610	FELV3281-AD	Cat cell line derived from lymphoma.
RCB2611	MDCK-AD	Dog cell line derived from kidney.
RCB2614	KLN205-MUC1	Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).
RCB2618	BCL1-B20	Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).
RCB2619	L929	Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).
RCB2620	C-1300N18	Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration
RCB2621	M1(D+)	Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).
RCB2623	KLN205	Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).
RCB2627	BOY-12E	Human cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).
RCB2630	B16F10	Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).
RCB2633	MM46 CEA1-2	Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).
RCB2634	MM46-APR-MUC1 cl.1	Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).
RCB2637	A4	Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).
RCB2638	B16/BL6	Mouse cell line derived from melanoma.　 TKG0598 (Deposited from Tohoku Univ.).
RCB2639	NB2a	Mouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).
RCB2640	G-415	Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
RCB2642	MUSS	Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497(Deposited from Tohoku Univ.).
RCB2643	F9	Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration
RCB2648	D4	A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). Cell growth is slow. TKG0300 (Deposited from Tohoku Univ.).
RCB2649	B16F1	Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).
RCB2651	JLS-V9	Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).
RCB2652	J774-1	Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).
RCB2657	Colon-26	Mouse cell line derived from colon cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).
RCB2660	MEDEP-E14	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.
RCB2686	JTC-35	Bovine granulosa cell line.
RCB2691	MEDEP-E14 clone 4	A subclone of MEDEP-E14(RCB2660) following cloning procedure.
RCB2692	MEDEP-BRC4-1	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.
RCB2693	MEDMC-NT2	Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.
RCB2694	MEDMC-BRC6	Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.
RCB2695	RD-C2	Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
RCB2696	RD-C6	Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
RCB2700	PK-8	Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).
RCB2709	2F8	Hybridoma producing monoclonal antibody against oxitocin receptor.
RCB2710	Atg5^(+/+)MEF	Mouse embryonic fibroblasts. Wild type control for RCB2711.
RCB2711	Atg5^(-/-)MEF	Mouse embryonic fibroblasts lacking Atg5 gene expression.
RCB2712	MAEC	Mouse cell line derived from aorta of p53-deficient mouse. Epithelial like.
RCB2718	MT-7	Rat cell line derived from fibrous histiocytoma. After cloning.
RCB2719	MT-10	Rat cell line derived from fibrous histiocytoma. After cloning.
RCB2720	MT-R8	A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2721	MT-R9	A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2722	MT-10R	A subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
RCB2723	MT-PR	A subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. The parent cell line, MT-P, is also deposited but not available yet.
RCB2724	KB-D8	Rat cell line derived from dendritic cell carcinoma in thymus.
RCB2725	KJ-A	Rat cell line derived from malignant fibrous histiocytoma.
RCB2726	KE-F11	Rat cell line derived from malignant schwannoma.
RCB2727	RY-B-E3	Rat cell line derived from endometrial stromal sarcoma.
RCB2728	LY-H12	Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.
RCB2729	LY-PPB6	Rat cell line derived from malignant peripheral nerve sheath tumor.
RCB2740	5-WASP	Hybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein).TKG0631 (Deposited from Tohoku Univ.).
RCB2745	A20	Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).
RCB2758	LAG	Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).
RCB2766	Morris 5123D-TC	Rat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).
RCB2767	NIH/3T3	Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).
RCB2776	P388	Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).
RCB2782	RBL 2H3	Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).
RCB2783	RGC-6	Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).
RCB2784	RL♂1(Gloria)	Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).
RCB2799	YAC-1	Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).
RCB2800	PC12-F7	A subline of PC-12 lacking synaptotagmin-1.
RCB2801	PC12-G11	A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.
RCB2806	MSK-C5.8G	Rat cell line derived from osteosarcoma. F344 strain.
RCB2808	Odf2-deficient F9 cells	A subline of mouse ES cell line, F9 (129), lacking Odf2.
RCB2809	CH12F3-2A	Mouse cell line derived from B cell lymphoma.
RCB2811	7F9 (hybridoma)	Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.
RCB2812	HeLa/Fucci	A subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4.Important notice regarding nomenclature of Fucci.
RCB2813	NMuMG/Fucci	A subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.
RCB2815	P20.1	Hybridoma producing monoclonal antibody against a peptide, GYPGQV.
RCB2816	A110L	Human cell line derived from lung adenocarcinoma cells.
RCB2817	A529L	Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.
RCB2818	B1203L	Human cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.
RCB2819	C831L	Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.
RCB2830	OMC-2	Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.
RCB2831	DEOC-1	Human cell line derived from malignant melanoma. Cell growth is slow.
RCB2832	OMC-9	Human cell line derived from endometrial stromal sarcoma.
RCB2833	L23immo	Human immortalized cell line derived from MRC5 cells.
RCB2834	L12.9-2(1)	Human immortalized cell line derived from MRC5 cells.
RCB2843	43L	Somatic tumor hybrid (fusion cell between C3H mammary tumor FM3A#2 and 8-Ag resistant L cell). This hybrid tumor cells induce resistance to MM Ag positive tumor cells. TKG0381 (Deposited from Tohoku Univ.).
RCB2844	L1210 TGR4	Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478(Deposited from Tohoku Univ.).
RCB2845	L1210-5FU-R-TC	Mouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).
RCB2846	LAG-MUC1	A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).
RCB2848	OTT6050(B)	Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330(Deposited from Tohoku Univ.).
RCB2852	TSA8	Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370(Deposited from Tohoku Univ.).
RCB2853	WEHI-3B	Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).
RCB2854	C6	Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).
RCB2859	K-251	Rat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).
RCB2860	MRMT-1	Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).
RCB2862	SLC	Rat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).
RCB2863	N14.5	Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
RCB2864	OLP6	Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
RCB2867	HeLa/Fucci2	A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.
RCB2868	NMuMG/Fucci2	A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5. Important notice regarding nomenclature of Fucci.
RCB2869	CHO-K1	A subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).
RCB2896	JLS-V9 6TG	Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350(Deposited from Tohoku Univ.).
RCB2899	S180-Kumamoto-TC	Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).
RCB2900	S180-Meiji-TC	Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).
RCB2901	S180-NCC-TC	Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).
RCB2904	WEHI164R	Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).
RCB2905	WEHI164S	Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).
RCB2908	AH272-TC	Rat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).
RCB2909	Walker256-TC	Rat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).
RCB2910	LY-6-TC	Rat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).
RCB2911	MEDEP-BRC5	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.
RCB2924	OP9/G	Subline of OP9 cell line, expressing EGFP. Cell growth is slow.　See RCB2117 TSt-4/G.
RCB2925	OP9/G-DLL1	Subline of OP9 cell line, expressing DLL1 and EGFP. Cell growth is slow. See RCB2118 TSt-4/G-DLL1.
RCB2926	OP9/N	Subline of OP9 cell line, expressing human NGF receptor. Cell growth is slow. See RCB2119 TSt-4/N.
RCB2927	OP9/N-DLL1	Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.
RCB2931	6E2	Hybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.
RCB2932	MEDEP-BRC4-2	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.
RCB2942	OLHNI-2	Medaka cell line derived from HNI strain.
RCB2943	OLHdrR-e3	Medaka cell line derived from HdrR strain.
RCB2944	OLCAB-e31	Medaka cell line.
RCB2945	DIT29	Medaka cell line derived from hepatoma cells.
RCB2946	OLCAB-e3	Medaka cell line.
RCB2979	HCT116	Human cell line derived from colon cancer.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2980	HCT116-XRCC4(+/-)	Subline of HCT116 cell line lacking XRCC4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2981	HCT116-XRCC4(-/-)	Subline of HCT116 cell line lacking XRCC4 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2982	HCT116-RAD18(+/-)	Subline of HCT116 cell line lacking RAD18 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2983	HCT116-RAD18(-/-)	Subline of HCT116 cell line lacking RAD18 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2984	HCT116-ARTEMIS(+/-)	Subline of HCT116 cell line lacking ARTEMIS gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2985	HCT116-ARTEMIS(-/-)	Subline of HCT116 cell line lacking ARTEMIS gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2986	HCT116-MDC1(+/-)	Subline of HCT116 cell line lacking MDC1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2987	HCT116-MDC1(-/-)	Subline of HCT116 cell line lacking MDC1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2988	HCT116-REV1(+/-)	Subline of HCT116 cell line lacking REV1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2989	HCT116-REV1(-/-)	Subline of HCT116 cell line lacking REV1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2990	HCT116-REV3L(+/-)	Subline of HCT116 cell line lacking REV3L gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2991	HCT116-KU70(+/-)	Subline of HCT116 cell line lacking Ku70 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2992	HCT116-DNAPKcs(+/-)	Subline of HCT116 cell line lacking DNAPKcs gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2993	HCT116-POLM(+/-)	Subline of HCT116 cell line lacking DNA polymerase m gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2994	HCT116-LIG3(+/-)	Subline of HCT116 cell line lacking Ligase 3 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2995	HCT116-LIG4(+/-)	Subline of HCT116 cell line lacking Ligase 4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2996	HCT116-53BP1(+/-)	Subline of HCT116 cell line lacking 53BPI gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
RCB2997	H414	Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).
RCB2998	H414-RAD18(+/-)	Subline of H414 cell line lacking RAD18 gene in one allele.
RCB2999	H414-RAD18(-/-)	Subline of H414 cell line lacking RAD18 gene in both alleles.
RCB3000	H414-MDC1(+/-)	Subline of H414 cell line lacking MDC1 gene in one allele.
RCB3001	H414-MDC1(-/-)	Subline of H414 cell line lacking MDC1 gene in both alleles.
RCB3002	H414-LIG4(+/-)	Subline of H414 cell line lacking Ligase 4 gene in one allele.
RCB3007	MOPC-70A	Mouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).
RCB3008	NC37	HGPRT(-), resistant to ouabain, partner cells for human B hybridoma. Ig nonproducer, human B lymphoblastoid cell line. This line and Raji (TKG0371)are derived from the same individual. TKG0232 (Deposited from Tohoku Univ.).
RCB3010	RPMI8226	Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).
RCB3052	Jurkat	Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).
RCB3515	JLS-V9 BudR	Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356(Deposited from Tohoku Univ.).
RCB3530	B901L	Human cell line derived from lung adenocarcinoma cells.
RCB3531	A904L	Human cell line derived from lung large cell carcinoma cells.
RCB3532	A129L	Human cell line derived from lung adenocarcinoma cells.
RCB3576	Aska-SS	Human cell line derived from synovial sarcoma.
RCB3577	Yamato-SS	Human cell line derived from synovial sarcoma.
RCB3586	hPSC-1	Human cell line derived from choronic pancreatitis. Pancreatic stellate cells.
RCB3588	hPSC-5	Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
RCB3589	hPSC-14	Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
RCB3600	SDR-P-1D5	Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.
RCB3601	SDRL-1	Rat cell line derived from liver lacking growth hormone.
RCB3602	SDRL-2	Rat cell line derived from liver lacking growth hormone.
RCB3673	Raji	Human cell line derived from Burkitt lymphoma. EBNA (EBV—nuclear antigen) positive. TKG0371(Deposited from Tohoku Univ.).
RCB3675	SCC-TC	Rectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).
RCB3676	5637	Human cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).
RCB3677	A549	Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184(Deposited from Tohoku Univ.).
RCB3678	BeWo	Human cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).
RCB3680	HeLa	Human cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).
RCB3681	HeLa.P3(S)	Subline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).
RCB3682	HeLa S3	Human cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).
RCB3683	HL-60	Human cell line derived from promyelocytic leukemia cells. TKG0345 (Deposited from Tohoku Univ.).
RCB3685	HMV-II	Human cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).
RCB3686	THP-1	Human cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).
RCB3687	MKN-7	Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).
RCB3688	Saos-2	Human cell line derived from osteogenic sarcoma cells. TKG0469 (Deposited from Tohoku Univ.).
RCB3706	Atg7 +/+ MEFs	Mouse embryonic fibroblasts derived from wild type mouse (C57BL/6).
RCB3707	Atg7 -/- MEFs	Mouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).
RCB3708	Atg3 +/+ MEFs	Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.
RCB3709	Atg3 -/- MEFs	Mouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.
RCB3710	CRP2(A1311A)	Currently not ready. Hybridoma against CRP2 (full length) antigen.
RCB3711	CDX2(A3701A)	Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3712	CDX2(A3707A)	Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3713	CDX2(A371)	Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3714	CDX2(A3719A)	Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3715	CDX2(A3722A)	Currently not ready. Hybridoma against CDX2 (full length) antigen.
RCB3716	NNMT(A2402A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3717	NNMT(A2418A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3718	NNMT(A2433A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3719	NNMT(A2434A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3720	NNMT(A2438A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3721	NNMT(A2440A)	Currently not ready. Hybridoma against NNMT (full length) antigen.
RCB3722	Olig1(A5501A)	Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3723	Olig1(A5507A)	Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3724	Olig1(A5508A)	Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3725	Olig1(A551)	Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3726	Olig1(A5518A)	Currently not ready. Hybridoma against Olig1 (full length) antigen.
RCB3727	Olig2(A5618A)	Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3728	Olig2(A5628A)	Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3729	Olig2(A5629A)	Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3730	Olig2(A5643A)	Currently not ready. Hybridoma against Olig2 (full length) antigen.
RCB3731	SFRP4(A7113A)	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3732	SFRP4(A7116-2A)	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3733	SFRP4(A7118A)	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3734	SFRP4(A7123A)	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3735	SFRP4(A7127-74A)	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
RCB3736	EPST11(H9209)	Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3737	EPST11(H9214)	Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3738	EPST11(H9219)	Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3739	EPST11(H9220)	Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3740	EPST11(H9228)	Currently not ready. Hybridoma against EPST11 (full length) antigen.
RCB3741	C20-ORF102(H9613)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3742	C20-ORF102(H9615)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3743	C20-ORF102(H9616)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3744	C20-ORF102(H9625)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3745	C20-ORF102(H9627)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3746	C20-ORF102(H9638)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3747	C20-ORF102(H9645)	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
RCB3748	SP-D5(N2901)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3749	SP-D5(N2906)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3750	SP-D5(N2922)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3751	SP-D5(N2927)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3752	SP-D5(N2931)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3753	SP-D5(N2933)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3754	SP-D5(N2935)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3755	SP-D5(N2942)	Currently not ready. Hybridoma against SP-D5 (full length) antigen.
RCB3756	PTCH1-2(N7333)	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3757	PTCH1-2(N7346)	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3758	PTCH1-2(N7357)	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
RCB3759	PLCη2C(N8320)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3760	PLCη2C(N8328)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3761	PLCη2C(N8339)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3762	PLCη2C(N8346)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3763	PLCη2C(N8351)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3764	PLCη2C(N8353)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3765	PLCη2C(N8357)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3766	PLCη2C(N8360)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3767	PLCη2C(N8361)	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
RCB3768	Prdm14-2(N8028)	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3769	Prdm14-2(N8048)	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3770	Prdm14-2(N8070)	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
RCB3771	Prdm1-2(N6902)	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3772	Prdm1-2(N6915)	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3773	Prdm1-2(N6916)	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3774	Prdm1-2(N6917)	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3775	Prdm1-2(N6927)	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
RCB3776	HZF2(Y3701)	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3777	HZF2(Y3713)	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3778	HZF2(Y3716)	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
RCB3779	HZF3(Y3901)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3780	HZF3(Y3916)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3781	HZF3(Y3919)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3782	HZF3(Y3921)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3783	HZF3(Y3923)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3784	HZF3(Y3924)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3785	HZF3(Y3928)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3786	HZF3(Y3932)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3787	HZF3(Y3942)	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
RCB3788	HZF4(Y4006)	Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
RCB3789	HZF4(Y4019)	Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
RCB3790	tead2(Y3312)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3791	tead2(Y3321)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3792	tead2(Y3324)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3793	tead2(Y3325)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3794	tead2(Y3329)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3795	tead2(Y3331)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3796	tead2(Y3336)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3797	tead2(Y3339)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3798	tead2(Y3342)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3799	tead2(Y3343)	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
RCB3800	SOCS1-1(Y9208)	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3801	SOCS1-1(Y9213)	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3802	SOCS1-1(Y9215)	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
RCB3803	Prdm14-1(N8902)	Currently not ready. Hybridoma against Prdm14-1 : PR domain containing14 (1-100(100aa)) antigen.
RCB3804	CDK-11(Z0410)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3805	CDK-11(Z0418)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3806	CDK-11(Z0425)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3807	CDK-11(Z0430)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3808	CDK-11(Z0432)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3809	CDK-11(Z0441)	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
RCB3810	Neurotonin3(Z0835)	Currently not ready. Hybridoma against Neurotonin3 : Neurotonin (409-507(99aa)) antigen.
RCB3811	Neurotonin4(Z0901-265)	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3812	Neurotonin4(Z0937)	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3813	Neurotonin4(Z0953)	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3814	Neurotonin4(Z0956(222))	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
RCB3815	AKAP15(Y0319)	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3816	AKAP15(Y0329)	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3817	AKAP15(Y0332)	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3818	AKAP15(Y0335)	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3819	AKAP15(Y0348)	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
RCB3820	mGli2-2(N9106)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3821	mGli2-2(N9109)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3822	mGli2-2(N9110)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3823	mGli2-2(N9113)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3824	mGli2-2(N9119)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3825	mGli2-2(N9122)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3826	mGli2-2(N9124)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3827	mGli2-2(N9133)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3828	mGli2-2(N9143)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3829	mGli2-2(N9144)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3830	mGli2-2(N9145)	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(6a)) antigen.
RCB3831	SMO-2(B7115B)	Currently not ready. Hybridoma against SMO-2 : SMO (470-519 (50aa)) antigen.
RCB3832	Wnt4(N0716)	Currently not ready. Hybridoma against Wnt4 : Wnt4 (37-77 (41aa)) antigen.
RCB3833	Gli1(N5510)	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3834	Gli1(N5516-191)	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3835	Gli1(N5537)	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
RCB3836	SMO-1(N5813)	Currently not ready. Hybridoma against SMO-1 : SMO (90-172 (83aa)) antigen.
RCB3837	Gli3(N6202)	Currently not ready. Hybridoma against gp64 fusion Gli3 : GLI family zinc finger 3 (2-60 (59aa)) antigen expressed by baculovirus.
RCB3838	Calp7-1(Y0717)	Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
RCB3839	Calp7-1(Y0737)	Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
RCB3840	PEG10-1(H1805)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3841	PEG10-1(H1807)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3842	PEG10-1(H1812)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3843	PEG10-1(H1827)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3844	PEG10-1(H1829)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3845	PEG10-1(H1831)	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
RCB3846	TFF1deltaN(H6110)	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3847	TFF1deltaN(H6111)	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3848	TFF1deltaN(H6112)	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3849	TFF1deltaN(H6123)	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3850	TFF1deltaN(H6134)	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
RCB3851	STIP1(H3401)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3852	STIP1(H3408)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3853	STIP1(H3420)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3854	STIP1(H3425)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3855	STIP1(H3430)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3856	STIP1(H3444)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3857	STIP1(H3445)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3858	STIP1(H3454)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3859	STIP1(H3455)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3860	STIP1(H3456)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3861	STIP1(H1726)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3862	STIP1(H1731)	Currently not ready. Hybridoma against STIP1 (full length) antigen.
RCB3863	Rab32(H3502)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3864	Rab32(H3506)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3865	Rab32(H3512)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3866	Rab32(H3513)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3867	Rab32(H3516)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3868	Rab32(H3519)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3869	Rab32(H3521)	Currently not ready. Hybridoma against Rab32 (full length) antigen.
RCB3870	GBR7(H4720)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3871	GBR7(H4722)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3872	GBR7(H4733)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3873	GBR7(H4739)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3874	GBR7(H4747)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3875	GBR7(H4749)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3876	GBR7(H4750)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3877	GBR7(H4751)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3878	GBR7(H4752)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3879	GBR7(H4755)	Currently not ready. Hybridoma against GBR7 (full length) antigen.
RCB3880	FLJ20442(H5409)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3881	FLJ20442(H5413)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3882	FLJ20442(H5422)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3883	FLJ20442(H5425)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3884	FLJ20442(H5429)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3885	FLJ20442(H5432)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3886	FLJ20442(H5433)	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
RCB3887	Galectin4(H6004)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3888	Galectin4(H6005)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3889	Galectin4(H6006)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3890	Galectin4(H6007)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3891	Galectin4(H6009)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3892	Galectin4(H6013)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3893	Galectin4(H6015)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3894	Galectin4(H6024)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3895	Galectin4(H6026)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3896	Galectin4(H6034)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3897	Galectin4(H6038)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3898	Galectin4(H6043)	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
RCB3899	PAEP(H7001)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3900	PAEP(H7005)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3901	PAEP(H7006)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3902	PAEP(H7011)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3903	PAEP(H701)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3904	PAEP(H7020A)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3905	PAEP(H7026)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3906	PAEP(H7033)	Currently not ready. Hybridoma against PAEP (full length) antigen.
RCB3907	PGC-1(H5953)	Currently not ready. Hybridoma against PGC-1 (2-81(80aa)) antigen.
RCB3908	STK15(H5701)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3909	STK15(H5706)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3910	STK15(H5716)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3911	STK15(H5723)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3912	STK15(H5725)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3913	STK15(H5728)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3914	STK15(H5737)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3915	STK15(H5743)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3916	STK15(H5754)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3917	STK15(H5755)	Currently not ready. Hybridoma against STK15 (full length) antigen.
RCB3918	*MT(H8602)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3919	*MT(H8607)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3920	*MT(H8619)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3921	*MT(H8624)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3922	*MT(H8629)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3923	*MT(H8637)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3924	*MT(H8638)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3925	*MT(H8644)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3926	*MT(H8650)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3927	*MT(H8655)	Currently not ready. Hybridoma against *MT (full length) antigen.
RCB3928	DUSP9(H8901)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3929	DUSP9(H8902)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3930	DUSP9(H8905)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3931	DUSP9(H8913)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3932	DUSP9(H8914)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3933	DUSP9(H8915)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3934	DUSP9(H8921)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3935	DUSP9(H8922)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3936	DUSP9(H8925)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3937	DUSP9(H8942)	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
RCB3938	TIF2(H8403)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3939	TIF2(H8407)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3940	TIF2(H8411)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3941	TIF2(H8414)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3942	TIF2(H8424)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3943	TIF2(H8427)	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
RCB3944	SKIP(H8514)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3945	SKIP(H8515)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3946	SKIP(H8529)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3947	SKIP(H8530)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3948	SKIP(H8524)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3949	SKIP(H8531)	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
RCB3950	TRIP13(H9319)	Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
RCB3951	TRIP13(H9341)	Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
RCB3952	RCN2(H9757)	Currently not ready. Hybridoma against RCN2 (2-99 (98aa)) antigen.
RCB3953	RBP2(H9807)	Currently not ready. Hybridoma against RBP2 (2-99 (98aa)) antigen.
RCB3954	PGC1b-2(N5702)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3955	PGC1b-2(N5704)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3956	PGC1b-2(N5708)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3957	PGC1b-2(N5715)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3958	PGC1b-2(N5719)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3959	PGC1b-2(N5720)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3960	PGC1b-2(N5722)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3961	PGC1b-2(N5723)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3962	PGC1b-2(N5739)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3963	gp64(B8109B)	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3964	gp64(B8121A)	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3965	gp64(B8137A)	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3966	gp64(B8140A)	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3967	gp64(B8147A)	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
RCB3968	mMTMR6(N7705)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3969	mMTMR6(N7706)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3970	mMTMR6(N7712)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3971	mMTMR6(N7715)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3972	mMTMR6(N7725)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3973	mMTMR6(N7739)	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
RCB3974	SAV-1-N1(Z2011)	Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
RCB3975	SAV-1-N1(Z2020)	Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
RCB3976	hPPARα-1(Y1820)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3977	hFRS2β1(Y7607)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB3978	hPPARα-1(Y1846)	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
RCB3979	hRev-erbα-1(Y2313)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3980	hRev-erbα-1(Y2319)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3981	hRev-erbα-1(Y2325)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3982	hRev-erbα-1(Y2336)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3983	hRev-erbα-1(Y2339)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3984	hRev-erbα-1(Y2340)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3985	hRev-erbα-1(Y2347)	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
RCB3986	DKK1(H2907)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3987	DKK1(H2910)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3988	DKK1(H2913)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3989	DKK1(H2914)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3990	DKK1(H2922)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3991	DKK1(H2927)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3992	DKK1(H2928)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3993	DKK1(H2933)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3994	DKK1(H2936)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3995	DKK1(H2940)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3996	DKK1(H2945)	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
RCB3997	hNDR2C(Z1419)	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB3998	hNDR2C(Z1440)	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB3999	hNDR2C(Y5118)	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
RCB4000	NFIA1(Y2230)	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4001	NFIA1(Y2236)	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4002	NFIA1(Y2238)	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4003	NFIA1(Y2240)	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
RCB4004	NFIB3(Y2823)	Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
RCB4005	NFIB3(Y2833)	Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
RCB4006	NFIX1(Y4402)	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4007	NFIX1(Y4406)	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4008	NFIX1(Y4418)	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4009	NFIX1(Y4424)	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
RCB4010	hNRF2-3(Y4902)	Currently not ready. Hybridoma against NFIX1 : hNRF2-3 : Nuclear factor erythroid2-related factor 2 (331-390(60aa)) antigen.
RCB4011	Bach1-H1(N9502)	Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
RCB4012	Bach1-H1(N9516)	Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
RCB4013	Bach1-H2(Y0208)	Currently not ready. Hybridoma against NFIX1 : Bach1-H2 : BTB and CNC homology 1 (637-725(89aa)) antigen.
RCB4014	Bach1-M1(N9602)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4015	Bach1-M1(N9609)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4016	Bach1-M1(N9610)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4017	Bach1-M1(N9611)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4018	Bach1-M1(N9613)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4019	Bach1-M1(N9628)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4020	Bach1-M1(N9639)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4021	Bach1-M1(N9642)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4022	Bach1-M1(N9647)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4023	Bach1-M1(N9648)	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(7a)) antigen.
RCB4024	Bach1-M2(Y2103)	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4025	Bach1-M2(Y2117)	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4026	Bach1-M2(Y2133)	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
RCB4027	DRPLA-2(N9330)	Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
RCB4028	DRPLA-2(N9331)	Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
RCB4029	DRPLA-4(Y0435)	Currently not ready. Hybridoma against DRPLA-4 : Dentato-rubro-pallido-luysian atrophy (1085-1184(100aa)) antigen.
RCB4030	hPTK7-Cyto(Y2040)	Currently not ready. Hybridoma against hPTK7-Cyto : Tyrosine-protein kinase-like 7 (725-795(70aa)) antigen.
RCB4031	hPTK7-Extra(Y1927)	Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
RCB4032	hPTK7-Extra(Y1937)	Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
RCB4033	MEF2A-3(Y0809)	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4034	MEF2A-3(Y0833)	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4035	MEF2A-3(Y0834)	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4036	MEF2A-3(Y0841)	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4037	MEF2A-3(Y0847)	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
RCB4038	MEF2C-2(Y1728)	Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
RCB4039	MEF2C-2(Y1740)	Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
RCB4040	AFP(B2007C)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4041	AFP(B2011D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4042	AFP(B2015C)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4043	AFP(B2117C)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4044	AFP(B2150D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4045	AFP(B2151D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4046	TFF1(N2306)	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4047	TFF1(N2309)	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4048	TFF1(N2320)	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4049	TFF1(N2325)	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
RCB4050	mGCNF-Hinge(N6724)	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4051	mGCNF-Hinge(N6729)	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4052	mGCNF-Hinge(N6737)	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4053	mGCNF-Hinge(N6760)	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
RCB4054	mGCNF-N(N6807)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4055	mGCNF-N(N6812)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4056	mGCNF-N(N6813)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4057	mGCNF-N(N6816)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4058	mGCNF-N(N6819)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4059	mGCNF-N(N6823)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4060	mGCNF-N(N6824)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4061	mGCNF-N(N6831)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4062	mGCNF-N(N6832)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4063	mGCNF-N(N6836)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4064	mGCNF-N(N6839)	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
RCB4065	hFOXP3(B8905-6)	Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
RCB4066	hFOXP3(B8916B)	Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
RCB4067	PPARdelta-1(2-45)(C0309A)	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4068	PPARdelta-1(2-45)(C0309B)	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4069	PPARdelta-1(2-45)(C0309C)	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
RCB4070	hRev-erbα-2(Y2408)	Currently not ready. Hybridoma against hRev-erbα-2 : Rev-erbα (41-80(40aa)) antigen.
RCB4071	hHNF4ɤ-1(Y4602)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4072	hHNF4ɤ-1(Y4611)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4073	hHNF4ɤ-1(Y4618)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4074	hHNF4ɤ-1(Y4621)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4075	hHNF4ɤ-1(Y4623)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4076	hHNF4ɤ-1(Y4625)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4077	hHNF4ɤ-1(Y4626)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4078	hHNF4ɤ-1(Y4635)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4079	hHNF4ɤ-1(Y4643)	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
RCB4080	Cys-SN2(N3306)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4081	Cys-SN2(N3312)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4082	Cys-SN2(N3316)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4083	Cys-SN2(N3323)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4084	Cys-SN2(N3331)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4085	Cys-SN2(N3338)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4086	Cys-SN2(N3344)	Currently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
RCB4087	Cys-SN2(N3346)	Currently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
RCB4088	Cys-SN2(N3349)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4089	Cys-SN2(N3372)	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4090	TRβ-CT(H9401)	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4091	TRβ-CT(H9420)	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4092	TRβ-CT(H9431)	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4093	TRβ-CT(H9437)	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
RCB4094	mGli2(N7206)	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4095	mGli2(N7212)	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4096	mGli2(N7219)	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4097	mGli2(N7237)	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
RCB4098	mTES101-RP(N6002)	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4099	mTES101-RP(N6022A)	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4100	mTES101-RP(N6022B)	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4101	mTES101-RP(N6035)	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4102	mTES101-RP(N6038)	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
RCB4103	TADA3(B0331A)	Currently not ready. Hybridoma against TADA3 (3-49 (61-160 (100aa)) antigen.
RCB4104	WBP2(N2617)	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4105	WBP2(N2640)	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4106	WBP2(N2645)	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
RCB4107	AI-gp(Y3111)	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4108	AI-gp(Y3123)	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4109	AI-gp(Y3124)	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4110	AI-gp(Y3127)	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4111	AI-gp(Y3147)	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
RCB4112	AFP(B592)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4113	AFP(B5937F)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4114	AFP(B5939D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4115	AFP(B5944F)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4116	AFP(B5955D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4117	AFP(B5963D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4118	AFP(B5980D)	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
RCB4119	CCR5 SP3(Y4108)	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4120	CCR5 SP3(Y4125)	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4121	CCR5 SP3(Y4126)	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
RCB4122	mNCoR-1(Y8110)	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4123	mNCoR-1(Y8111)	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4124	mNCoR-1(Y8129)	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4125	mNCoR-1(Y8131(A))	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
RCB4126	mSRC-1(Y8207)	Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
RCB4127	mSRC-1(Y8243)	Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
RCB4128	HSMRT(Y9017)	Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
RCB4129	HSMRT(Y9033)	Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
RCB4130	hRIP140(Y9140)	Currently not ready. Hybridoma against hRIP140 (733-847(11a)) antigen.
RCB4131	hTIF2(Y8917)	Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
RCB4132	hTIF2(Y8918)	Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
RCB4133	BAP37(Z1131B)	Currently not ready. Hybridoma against BAP37 : B-cell receptor-associated protein 37 (210-249(40aa)) antigen.
RCB4134	SOX21 PepT3(Z3001)	Currently not ready. Hybridoma against SOX21 PepT3 : SRY (sex determining region Y)-box 21 (129-176(48aa)) antigen.
RCB4135	Epc1AG(Z3703)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4136	Epc1AG(Z3705)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4137	Epc1AG(Z3710)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4138	Epc1AG(Z3714)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4139	Epc1AG(Z3715)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4140	Epc1AG(Z3716)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4141	Epc1AG(Z3725)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4142	Epc1AG(Z3728)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4143	Epc1AG(Z3733)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4144	Epc1AG(Z3741)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4145	Epc1AG(Z3742)	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
RCB4146	Epc2AG(Z3901)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4147	Epc2AG(Z3906)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4148	Epc2AG(Z3908)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4149	Epc2AG(Z3911)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4150	Epc2AG(Z3921)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4151	Epc2AG(Z3922)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4152	Epc2AG(Z3925)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4153	Epc2AG(Z3931)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4154	Epc2AG(Z3934)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4155	Epc2AG(Z3940)	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
RCB4156	STK3(Z2801)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4157	STK3(Z2804)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4158	STK3(Z2814)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4159	STK3(Z2816)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4160	STK3(Z2822)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4161	STK3(Z2828)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4162	STK3(Z2829)	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(5a)) antigen.
RCB4163	mDAI-3S(Z4401)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4164	mDAI-3S(Z4410)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4165	mDAI-3S(Z4415)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4166	mDAI-3S(Z4420)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4167	mDAI-3S(Z4424)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4168	mDAI-3S(Z4429)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4169	mDAI-3S(Z4402)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4170	mDAI-3S(Z4418)	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
RCB4171	JHDM2A-3C(Z5507)	Currently not ready. Hybridoma against JHDM2A-3C : Jumonji domain containing gene family of histone demethylase 2A (1151-1224(74aa)) antigen.
RCB4172	JHDM2A-4C(Z6316)	Currently not ready. Hybridoma against JHDM2A-4C : Jumonji domain containing gene family of histone demethylase 2A (1089-1138(50aa)) antigen.
RCB4173	HIF1(Z6413)	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4174	HIF1(Z6414)	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4175	HIF1(Z6417)	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4176	HIF1(Z6437)	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(4a)) antigen.
RCB4177	HIF2(Z6502)	Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
RCB4178	HIF2(Z6526)	Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
RCB4179	p65-12(Z6635)	Currently not ready. Hybridoma against p65-12 : p65 (116-168(53aa)) antigen.
RCB4180	Mrf2-2(Z7411)	Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
RCB4181	Mrf2-2(Z7437)	Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
RCB4182	THRAP3(Z6803)	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4183	THRAP3(Z6824)	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4184	THRAP3(Z6832)	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4185	THRAP3(Z6840)	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
RCB4186	KLF4(Z6902)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4187	KLF4(Z6913)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4188	KLF4(Z6919)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4189	KLF4(Z6928)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4190	KLF4(Z6929)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4191	KLF4(Z6943)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4192	KLF4(Z6944)	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(6a)) antigen.
RCB4193	CCR4aN(Y6206)	CCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4194	CCR4bC(Y5601)	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4195	CCR4bC(Y5606)	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4196	CCR4bC(Y5657)	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(5a)) antigen.
RCB4197	SETD3(Y2501)	Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
RCB4198	SETD3(Y2537)	Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
RCB4199	mSETDB2-1(Y7221)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4200	mSETDB2-1(Y7227)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4201	mSETDB2-1(Y7228)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4202	mSETDB2-1(Y7232)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4203	mSETDB2-1(Y7241)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4204	mSETDB2-1(Y7246)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4205	mSETDB2-1(Y7247)	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
RCB4206	Prdm6-2(Y7126)	Currently not ready. Hybridoma against Prdm6-2 : PR domain containing 6 (294-392(99aa)) antigen.
RCB4207	Prdm16-1(Z0311)	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4208	Prdm16-1(Z0315)	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4209	Prdm16-1(Z0324)	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4210	Prdm16-1(Z0327)	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4211	Prdm16-1(Z0346)	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
RCB4212	Prdm16-2(Z1301)	Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4213	Prdm16-2(Z1312)	Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4214	Prdm16-2(Z1322)	Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
RCB4215	Prdm2-2(Z0601)	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4216	Prdm2-2(Z0605)	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4217	Prdm2-2(Z0626)	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4218	Prdm2-2(Z0631)	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4219	Prdm2-2(Z0654)	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
RCB4220	Prdm4-1(Y8328)	Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
RCB4221	Prdm4-1(Y8341)	Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
RCB4222	COUP TFII-2(Z0504)	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4223	COUP TFII-2(Z0523)	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4224	COUP TFII-2(Z0533)	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
RCB4225	methylated budded baculovirus(C4914-2)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4226	methylated budded baculovirus(C4930-101)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4227	methylated budded baculovirus(C5006-9)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4228	methylated budded baculovirus(C5009-33)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4229	methylated budded baculovirus(C5032-60)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4230	methylated budded baculovirus(C5123-70)	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
RCB4231	ATIP-CT(N4204)	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4232	ATIP-CT(N4207)	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4233	ATIP-CT(N4235)	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
RCB4234	ROBO1 Ag1(Y4314)	Currently not ready. Hybridoma against ROBO1 Ag1 : Roundabout 1 (946-1034(89aa)) antigen.
RCB4235	ROBO1 Ag2(Y7002)	Currently not ready. Hybridoma against ROBO1 Ag2 : Roundabout 1 (1062-1148(87aa)) antigen.
RCB4236	ROBO1 Ag6(Y8411)	Currently not ready. Hybridoma against ROBO1 Ag6 : Roundabout 1 (1458-1555(98aa)) antigen.
RCB4237	APE-C(Y1202)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4238	APE-C(Y1209)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4239	APE-C(Y1215)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4240	APE-C(Y1220)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4241	APE-C(Y1221)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4242	APE-C(Y1244)	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
RCB4243	APE-N1(N9406)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4244	APE-N1(N9407)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4245	APE-N1(N9426)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4246	APE-N1(N9436A)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4247	APE-N1(N9436B)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4248	APE-N1(N9442)	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
RCB4249	APE-N3(Y0013)	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4250	APE-N3(Y0026)	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4251	APE-N3(Y0028)	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4252	APE-N3(Y0038)	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
RCB4253	hTobC(Y5432)	Currently not ready. Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
RCB4254	hTobC(Y5443)	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4255	hTobC(Y5444)	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4256	hTobC(Y5452)	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4257	hTobM(Y5807)	Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
RCB4258	hTobM(Y5815)	Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
RCB4259	p115-C(Y0902)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4260	p115-C(Y0912)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4261	p115-C(Y0915)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4262	p115-C(Y0920)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4263	p115-C(Y0921)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4264	p115-C(Y0924)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4265	p115-C(Y0931)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4266	p115-C(Y0945)	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
RCB4267	LARG-C term(Y9601)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4268	LARG-C term(Y9614)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4269	LARG-C term(Y9618)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4270	LARG-C term(Y9619)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4271	LARG-C term(Y9625)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4272	LARG-C term(Y9626)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4273	LARG-C term(Y9627)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4274	LARG-C term(Y9637)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
RCB4276	ATIP-CT(C1708-1)	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
RCB4277	ATIP-CT(C1717-5)	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
RCB4278	NM6(Y0620)	Currently not ready. Hybridoma against NM6 : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4279	NM6s(Y67002)	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4280	NM6s(Y67003)	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4281	NM6s(Y67057)	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4282	NM6s(Y67081)	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4283	NM6s(Y67109)	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
RCB4284	CM1s(Z1001)	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4285	CM1s(Z1002)	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4286	CM1s(Z1014)	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4287	CM1s(Z1016)	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4288	CM1s(Z1057)	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
RCB4289	CM6(Y9506)	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4290	CM6(Y9512)	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4291	CM6(Y9515)	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4292	CM6(Y9517)	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
RCB4293	hVir-2(Y1503)	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4294	hVir-2(Y1513)	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4295	hVir-2(Y1523)	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
RCB4296	hVir-3(Y1613)	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4297	hVir-3(Y1625(4C3))	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4298	hVir-3(Y1639)	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
RCB4299	WTAP(Y6809)	Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
RCB4300	WTAP(Y6828)	Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
RCB4301	hFRS2β1(Y7610)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4302	hFRS2β1(Y7612)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4303	hFRS2β1(Y7624)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4304	hFRS2β1(Y7632)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4305	hFRS2β1(Y7641)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4306	hFRS2β1(Y7642)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4307	hFRS2β1(Y7643)	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
RCB4308	mNFATC-N(Y7402)	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4309	mNFATC-N(Y7405)	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4310	mNFATC-N(Y7428)	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4311	mNFATC-N(Y7445)	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
RCB4312	hEgr1(N8605)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4313	hEgr1(N8611)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4314	hEgr1(N8614)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4315	hEgr1(N8616)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4316	hEgr1(N8637)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4317	hEgr1(N8640)	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
RCB4318	hEgr3(N8701)	Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
RCB4319	hEgr3(N8730)	Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
RCB4320	Prdm8-2(N8501)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4321	Prdm8-2(N8506)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4322	Prdm8-2(N8508)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4323	Prdm8-2(N8513)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4324	Prdm8-2(N8520)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4325	Prdm8-2(N8526)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4326	Prdm8-2(N8533)	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
RCB4327	Aggrecan-1(Y3416)	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4328	Aggrecan-1(Y3428)	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4329	Aggrecan-1(Y3431)	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4330	Aggrecan-1(Y3441)	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4331	Aggrecan-1(Y3446)	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
RCB4332	PTX3N46(Z3805(421))	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4333	PTX3N46(Z3818-1-19)	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4334	PTX3N46(Z3821(100))	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4335	PTX3N46(Z3825(125))	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4336	PTX3N46(Z3829-156)	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4337	PTX3N46(Z3835-467)	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4338	PTX3N46(Z3839-590)	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
RCB4339	CBLL1-2(Y6018)	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4340	CBLL1-2(Y6026)	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4341	CBLL1-2(Y6037)	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4342	CBLL1-2(Y6047)	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4343	CBLL1-2(Y6048)	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
RCB4344	CBLL1-1(Y6610)	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4345	CBLL1-1(Y6621)	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4346	CBLL1-1(Y6641)	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
RCB4347	PDZ-CS(Y7501)	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4348	PDZ-CS(Y7504)	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4349	PDZ-CS(Y7505)	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4350	PDZ-CS(Y7534)	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4351	PDZ-CS(Y7537)	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
RCB4352	Ets-1 Mid(Y8012)	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4353	Ets-1 Mid(Y8020)	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4354	Ets-1 Mid(Y8029)	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(8a)) antigen.
RCB4355	prdm 5(C2518A)	Currently not ready. Hybridoma against gp64 fusion prdm 5 : PR domain containing 5 (10-110(101aa)) antigen expressed by baculovirus.
RCB4356	RGS3T(C6501-4)	Currently not ready. Hybridoma against RGS3T : regular of G protein signaling 3 (full length) antigen.
RCB4357	Gq(C6604-5)	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4358	Gq(C6611A-11-A2)	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4359	Gq(C6611B-35-18)	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4360	Gq(C6618-81)	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4361	Gq(C6623-18)	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
RCB4362	Gα13(C9101-F5-1)	Currently not ready. Hybridoma against Gα13 : GNA12 (full length) antigen.
RCB4363	Gα13(C9201-B5-4)	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4364	Gα13(C9202-F9-1)	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4365	Gα13(C9204-D4-1)	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4366	Gα13(C9205-F6-4)	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
RCB4367	Gα12(D0901-A1-E11)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4368	Gα12(D0902-B12-G11)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4369	Gα12(D0904-A6-H2)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4370	Gα12(D0906-B10-D6)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4371	Gα12(D0907-E2-E8)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4372	Gα12(D0908-G5-A6)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4373	Gα12(D0910-G5-D10)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4374	Gα12(D0911-E6-G1)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4375	Gα12(D0912-B5-C9)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4376	Gα12(D0914-D5-D4)	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
RCB4377	NFATC-3(Z2705)	Currently not ready. Hybridoma against NFATC-3 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (35-107(73aa)) antigen.
RCB4378	mOSR-2(Z2914)	Currently not ready. Hybridoma against mOSR-2 : Odd-skipped related 2 (59-157(99aa) antigen.
RCB4379	ATOX1(Z3101)	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4380	ATOX1(Z3112)	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4381	ATOX1(Z3138)	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4382	ATOX1(Z3140)	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4383	ATOX1(Z3144)	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
RCB4384	MAN-1(Z4201)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4385	MAN-1(Z4202)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4386	MAN-1(Z4205)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4387	MAN-1(Z4209)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4388	MAN-1(Z4221)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4389	MAN-1(Z4222)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4390	MAN-1(Z4223)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4391	MAN-1(Z4237)	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
RCB4392	SETDB-1(Z4601)	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4393	SETDB-1(Z4606)	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4394	SETDB-1(Z4613)	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4395	SETDB-1(Z4630)	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
RCB4396	mp250GAP(Z4906)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4397	mp250GAP(Z4932)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4398	mp250GAP(Z4937)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4399	mp250GAP(Z4942)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4400	mp250GAP(Z4946)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4401	mp250GAP(Z4947)	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
RCB4402	SETD5-1(Z5235-36)	Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
RCB4403	SETD5-1(Z5235-42)	Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
RCB4404	NFATC1-2(Z5302)	Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
RCB4405	NFATC1-2(Z5321)	Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
RCB4406	GluR1-1(Z6114)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4407	GluR1-1(Z6119)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4408	GluR1-1(Z6123)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4409	GluR1-1(Z6135)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4410	GluR1-1(Z6141)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4411	GluR1-1(Z6143)	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
RCB4412	SETD5-4(Z5702-3)	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4413	SETD5-4(Z5704-209)	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4414	SETD5-4(Z5708-71)	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4415	SETD5-4(Z5714-114)	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4416	SETD5-4(Z5721-234)	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
RCB4417	PRMT1-N(Z5017)	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4418	PRMT1-N(Z5018)	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4419	PRMT1-N(Z5026)	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
RCB4420	NM1S/Tg(Z7332)	Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
RCB4421	NM1S/Tg(Z7342)	Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
RCB4422	CM3(Z7511)	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4423	CM3(Z7528)	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4424	CM3(Z7536)	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
RCB4425	NM3(Z8021)	Currently not ready. Hybridoma against NM3 : Myotubularin related protein 3 (1-50(50aa)) antigen.
RCB4426	CM4/Tg(Z8214)	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4427	CM4/Tg(Z8217)	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4428	CM4/Tg(Z8245B)	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
RCB4429	Fbxl 10-N(Z8310)	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4430	Fbxl 10-N(Z8312)	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4431	Fbxl 10-N(Z8320)	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4432	Fbxl 10-N(Z8327)	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4433	Fbxl 10-N(Z8345)	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
RCB4434	LARG-C term(D4004-4E2-6)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4435	LARG-C term(D4005-6A6-29)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4436	LARG-C term(D4101-2G11-41)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4437	LARG-C term(D4106-5G1-67)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4438	LARG-C term(D4107-5H2-110)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4439	LARG-C term(D4202-2E6-130)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4440	LARG-C term(D4204-1A10-163)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4441	LARG-C term(D4205-2A9-213)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4442	LARG-C term(D4206-2B8-221)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4443	LARG-C term(D4207-2D10-262)	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
RCB4444	Emerin Ab-3(D2702-12)	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4445	Emerin Ab-3(D2703-2)	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4446	Emerin Ab-3(D2704-5)	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4447	Emerin Ab-3(D2705-2)	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4448	Emerin Ab-3(D2738-2)	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
RCB4451	UPS-1	Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).
RCB4452	FL-YB	Mouse follicular dendritic cell line
RCB4455	PC-9	Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)
RCB4472	IN-IC	Rat cell line derived from kidney.
RCB4474	Ba/F3-CL1	Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3).　Information
RCB4476	Ba/F3	Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information
RCB4477	ACK2	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4478	ACK4	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4479	ACK30	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4480	ACK45	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
RCB4481	A7R34	Hybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.
RCB4482	APA5	Hybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.
RCB4483	APB5	Hybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.
RCB4484	Avas12	Hybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.
RCB4485	A2F10	Hybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.
RCB4486	AFS98	Hybridoma cell line producing anti-mouse c-fms (CD115) antibody.
RCB4487	ACD1	Hybridoma cell line producing anti-mouse CDK4 antibody.
RCB4488	AFL4	Hybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration
RCB4489	MB86	Hybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.
RCB4498	NP 2	Human cell line derived from anaplastic glioma.
RCB4499	Onda 10	Human cell line derived from anaplastic glioma.
RCB4500	Onda 11	Human cell line derived from glioblastoma.
RCB4504	NP 3	Human cell line derived from anaplastic glioma.
RCB4505	NP 5	Human cell line derived from anaplastic glioma.
RCB4516	STIM2^(-/-)DT40	A subline of avian cell line, DT40, lacking STIM2 gene.
RCB4517	STIM1^(-/-)STIM2^(-/-)DT40	A subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.
RCB4518	Orai1^(-/-)DT40	A subline of avian cell line, DT40, lacking Orai1 gene.
RCB4519	Orai2^(-/-)DT40	A subline of avian cell line, DT40, lacking Orai2 gene.
RCB4548	PT-r	Rat cell line derived from parathyroid gland.
RCB4561	MOLT-17	Human cell line derived from T cell leukemia (T-ALL). ACC 36 (Deposited from DMSZ.).
RCB4563	TSt-4/N-DLL4	Original murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.
RCB4566	TEC1C8
RCB4568	TEC2-3
RCB4569	TEC3-10
RCB4592	r/mHM-SFME-1
RCB4593	CALM WT MEF	CALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.
RCB4594	CALM KO MEF	CALM deficient MEF cells. Tranformed with SV40 large T antigen gene.
RCB4623	Ba/ER	Ba/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.
RCB4627	KUP5	An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution).
RCB4635	#16-15	Hybridoma cell line producing anti-human BEND3 antibody (rat IgM).
RCB4662	HCT116 CMV-OsTIR1	cf.： Kanemaki’s Auxin Inducible Degron (AID) System
RCB4676	HeLa/Fucci(CA)2	Important notice regarding nomenclature of Fucci.
RCB4679	HepG2-NIAS	A subline of HepG2 cells that can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum.
RCB4680	MS-5	Mouse stromal cell line which supports hematopoietic cells.
RCB4681	MS-K	Murine cell line derived from sarcoma.
RCB4683	6330403Rik
RCB4684	celf3
RCB4685	Dgcr14
RCB4693	ChR2-C2C12	A subline of the murine C2C12 cell line　(RCB0987) which stably expresses　channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.
RCB4695	GFP-LC3-RFP-LC3ΔG HeLa
RCB4696	GFP-LC3-RFP-LC3ΔG MEF
RCB4724	A2A(C2702-B05-52)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4725	A2A(C2704-C07-89)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4726	A2A(C2831-104)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4727	A2A(C2838-190)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4728	A2A(C3007-E6)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4729	A2A(C3019-B-203-B3)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4730	A2A(C3024-43)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4731	A2A(C3025-95)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4732	A2A(C3029A-236)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4733	A2A(C3044-10)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4734	A2A(C3080-145)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4735	A2A(C3138G3(A))	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4736	A2A(C3160-79)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4737	A2A(C3169-214)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4738	A2A(C3978B-D4)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4739	A2A(C3938B-F6)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4740	A2A(C3943B-E3)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4741	A2A(C40006-123)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4742	A2A(C40010-A6)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4743	A2A(C40011-G11)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4744	A2A(C40037-A5)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4745	A2A(C40040-A12)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4746	A2A(C40056-G6)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4747	A2A(C40076-173)	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
RCB4748	M2(C1801-A9-16)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4749	M2(C1802-B4-42)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4750	M2(C1803-C2-74)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4751	M2(C1805-E5-95)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4752	M2(C1901-C4-152)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4753	M2(C3603-D10-1)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4754	M2(C4729-H1-3)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4755	M2(C4804-3)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4756	M2(C4817-1)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4757	M2(C4814-E10-3)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4758	M2(C5708-1)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4759	M2(C5801-3)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4760	M2(C5903-1)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4761	M2(D0303-12)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4762	M2(D0368-63-A1-16)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4763	M2(D0403-13)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4764	M2(D0423-15)	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
RCB4765	Band3(C4201-A1-10)	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4766	Band3(C4203-D3-26)	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4767	Band3(C4204-C3-48)	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4768	Band3(C4206-G7-90)	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
RCB4769	Glut5(C45053-H4)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4770	Glut5(C45085-F2)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4771	Glut5(C45107-102)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4772	Glut5(C45019-3)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4773	Glut5(C45077-49)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4774	Glut5(C45106-78)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4775	Glut5(C45021-34)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4776	Glut5(C45004-016)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4777	Glut5(C45008-054)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4778	Glut5(C45037-101)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4779	Glut5(C45080-134)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4780	Glut5(C45081-146)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4781	Glut5(C45119-160)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4782	Glut5(C45124-214)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4783	Glut5(C45125-237)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4784	Glut5(C45032-73)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4785	Glut5(C45120-263-A4)	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
RCB4786	v-ATP ase VoV1(C87076-007)	Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
RCB4787	v-ATP ase VoV1(C87076-014)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4788	v-ATP ase VoV1(C87079-067)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4789	v-ATP ase VoV1(C87119-130)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4790	v-ATP ase VoV1(C87119-132)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4791	v-ATP ase VoV1(C87119-148)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4792	v-ATP ase VoV1(C87160-164)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4793	v-ATP ase VoV1(C87187-276)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4794	v-ATP ase VoV1(C87159B-111)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4795	v-ATP ase VoV1(C9017-349)	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
RCB4796	v-ATP ase CL(E72013-2C2-94)	Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
RCB4797	HRH1(D2205-A8)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4798	HRH1(D2210-C9)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4799	HRH1(D2201-D7)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4800	HRH1(D2315-H6)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4801	HRH1(D2335-A10)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4802	HRH1(D2351-H7)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4803	HRH1(D2335-F8)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4804	HRH1(D2363-H11)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4805	HRH1(D2326-G6-F12)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4806	HRH1(D2323-H5)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4807	HRH1(D2340-67)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4808	HRH1(D2401-E6)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4809	HRH1(D2503-B5)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4810	HRH1(D2510-110)	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
RCB4811	Glut1(D3638-22)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4812	Glut1(D3643-9)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4813	Glut1(D4425-2)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4814	Glut1(D4416-3)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4815	Glut1(D4417-14)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4816	Glut1(D4402-6)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4817	Glut1(D4418-30)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4818	Glut1(D4404-9)	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
RCB4831	AT2(D5604-006)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4832	AT2(D5614-054)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4833	AT2(D5608-040)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4834	AT2(D5647-129)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4835	AT2(D5655-150)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4836	AT2(D5630-095)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4837	AT2(D5605-011)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4838	AT2(D5640-072)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4839	AT2(D5620-032)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4840	AT2(D5626-060)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4841	AT2(D5711-4A03-B03)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4842	AT2(D5713-4C10-290)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4843	AT2(D5725-3B08-369)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4844	AT2(D5702-1A09-173)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4845	AT2(D5705-1E10-208)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4846	AT2(D5711-2H02-A01)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4847	AT2(D5714A-4D07-334)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4848	AT2(D5706-1F03-149)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4849	AT2(D5709-1H06-187)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4850	AT2(D5711-2H05-229)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4851	AT2(D5701-1A07-116)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4852	AT2(D5712-4A08-236)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4853	AT2(D5707-1G02-158)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4854	AT2(D5722-2D12-202)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4855	AT2(D5701-1A06-100)	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
RCB4856	TACR2(D8116-4C1-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4857	TACR2(D8103-3F12-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4858	TACR2(D8210-5D5-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4859	TACR2(D8213-1-3)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4860	TACR2(D83007-3)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4861	TACR2(D83010-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4862	TACR2(D83008-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4863	TACR2(D84042-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4864	TACR2(D84048-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4865	TACR2(D84072-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4866	TACR2(D84026-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4867	TACR2(D84083-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4868	TACR2(D84112-1)	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
RCB4869	GluR1-2(Z9139)	Currently not ready. Hybridoma against GluR1-2 (mouse) : GluA1 AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor (236~286 aa) antigen.
RCB4870	AQP4(C9401-A3-29)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4871	AQP4(D12092-1C3-02)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4872	AQP4(D15107-3D7-33)	Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4873	AQP4(E3634-13)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4874	AQP4(E3641-70)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4875	AQP4(E3635-60-A7)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4876	AQP4(E3726A-122)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4877	AQP4(E3716-94)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4878	AQP4(E3726B-130)	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
RCB4879	AQP4(E5206-1B10-8)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4880	AQP4(E5209-1C8-22)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4881	AQP4(E5407-1E6-32)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4882	AQP4(E5413-1G11-49)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4883	AQP4(E541-1H6-68)	Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4884	AQP4(E5415B-1H7-79)	Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4885	AQP4(E5507-3A1-113)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4886	AQP4(E5505-3D12-129)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4887	AQP4(E5504-2G2-105)	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
RCB4888	DP2(D5201-1A5-6)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4890	DP2(D5302-3A4-82)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4891	DP2(D5305-3B3-103)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4892	DP2(D5502-135)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4893	DP2(D5513-2-B1)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4894	DP2(D5516-176)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4895	DP2(D5517-208-A2)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4896	DP2(D5524-228)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4897	DP2(D5531-258)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4898	DP2(D5534-265)	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
RCB4899	NRF3-2(E9403-D3-A5-1)	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4900	NRF3-2(E9405-1)	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4901	NRF3-2(E9408-1)	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4902	NRF3-2(E9413-G1-A3-1)	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4903	NRF3-2(E9422-D2-B9-1)	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
RCB4907	DHHC1(D8013-1C11-6)	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4908	DHHC1(D8018-1D10-26)	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4909	DHHC1(D8018-1D10-35)	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
RCB4910	DHHC10(E2601-1C3-2)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4911	DHHC10(E2607-1F6-23)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4912	DHHC10(E2611-1H2-49)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4913	DHHC10(E2614-3B1-69)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4914	DHHC10(E2701-2B3-97)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4915	DHHC10(E2706-2F7-135)	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
RCB4936	CT27	TS culture protocol
RCB4937	CT29	TS culture protocol
RCB4938	CT30	TS culture protocol
RCB4940	bTS5	TS culture protocol
RCB4941	bTS11	TS culture protocol
RCB4942	BHK/T7-9
RCB5004	CHL-YN	Application consideration